Podcasts about accp

Andrea Wood, CEO of ACCP, The Association of Corporate Citizenship Professionals leads an extraordinary team that is creating purpose-driven companies. They advance the practice of corporate social impact by fostering a very vibrant peer network, providing practical guidance on how companies can become purpose driven and attract/retain young talent. ACCP is in a league of its own driving change in companies and communities. Their network of peer supports to help one another is unparalled. To change lives and position your company to be purpose driven, contact www.accp.org. It's not about writing a check to make your company look purpose driven. It's more about developing eco-systems within your company that your purpose driven actions are a part of the DNA. This program is brought to you by www.trulysignificant.com, launching another book in the series. Purchase at www.tinyurl.com/trulysignificantBecome a supporter of this podcast: https://www.spreaker.com/podcast/success-made-to-last-legends--4302039/support.

On March 19. 2025, The American College of Clinical Pharmacy published, "A review of antibiotic safety in pregnancy- 2025 Update". In this episode, we will review some of the confusion surrounding aminoglycosides, sulfa, and nitrofurantoin in pregnancy. Its interesting how different professions view certain medications in pregnancy. Does ACOG say you can use Sulfa in the third trimester? Can you use nitrofurantoin in the first trimester? Listen in for details. (SHOUT OUT to our partner podcast, CLINICAL PEARLS LATINO, for the topic idea. GRACIAS AMIGOS)

In 2020, the newly founded Truist Foundation was defining its philanthropic priorities when the COVID-19 pandemic changed everything. The Foundation quickly pivoted to provide rapid response support, setting up an open grant application portal and deploying an initial $25 million—which later doubled to $50 million—to provide critical relief to communities hit the hardest. This approach not only solidified Truist Foundation's commitment to community care but also laid the groundwork for how it would address future crises with urgency, empathy, and impact.This strategy became crucial when Hurricane Helene hit Western North Carolina in 2024, leaving 250,000 homes impacted across 39 counties. Truist Foundation, alongside the broader company, responded with a $700 million commitment to long-term recovery in the region. From immediate essentials like water and supplies to innovative support like mobile showers for impacted residents, Truist ensured aid went beyond financial assistance.We invited Lynette Bell, President of Truist Foundation, to discuss how Truist's commitment to disaster relief has evolved since the pandemic, the lessons learned along the way, and how their work continues to uplift communities with care, dignity, and long-term support.Listen for key insights on:The benefit of rapid response philanthropy when disasters hitHow to adapt philanthropic strategy in real time to meet urgent community needsHow Truist Foundation's work generates business valueResources + Links:Lynette Bell's LinkedInTruist FoundationTruist Foundation Grant ApplicationTruist Cares for Western North CarolinaInspire Awards (00:00) - Welcome to Purpose 360 (00:13) - Truist Foundation's Lynette Bell (01:52) - Lynette's Background (05:56) - The Name ‘Truist' (07:23) - Developing Purpose (08:11) - Heritage and Culture (10:50) - Grant Focus (13:39) - Humanity and Grace (16:59) - Long-Term Commitment (18:25) - Center for Disaster Philanthropy (19:46) - Inspire Awards (23:36) - ACCP 2023 Trailblazer Purpose Award (24:04) - Creating Business Value (24:45) - Last Words (25:22) - Wrap Up

Welcome to "Little Minds, Big Focus: ADHD Adventures in Pediatrics," where we explore the latest insights and strategies for treating ADHD in children. Join us as we navigate the unique challenges and triumphs of pediatric ADHD, offering expert advice, personal stories, and practical tips for parents and caregivers with our guest Dr. Lea Eiland. Tune in to discover the latest treatment guidelines, clinical pearls about stimulants and non-stimulants and non-pharmacological modalities for ADHD. Guest info: Dr. Lea Eiland is a Clinical Professor and Associate Department Head of Pharmacy Practice at Auburn University, Harrison College of Pharmacy. Dr. Eiland received her Doctor of Pharmacy degree from The University of Texas at Austin and completed a pediatric specialty residency at Texas Tech University. She joined the Auburn faculty in 2002 and is a board-certified pharmacotherapy and pediatric pharmacy specialist who has practiced in the general pediatric inpatient setting, pediatric ICU, and various pediatric clinics. Dr. Eiland is an active member of ASHP, PPA, ACCP, and AACP. She is currently a member of the PPA Board of Directors. She is a past member of the ASHP Board of Directors and past President of the Alabama Society of Health-System Pharmacists. Her career focuses on pharmacy education, pediatric clinical practice, professional organizational service, research/scholarship, mentorship, and leadership.

The director of respiratory therapy with UWF's Usha Kundu MD College of Health's Health Sciences and Administration Department has been awarded a highly sought-after "Fellow" title by the American College of Chest Physicians. Only approximately 125 members are given Fellow status each year nationwide. Amanda Dexter is one of about 20 Respiratory Therapists to ever receive a Fellowship award from ACCP, which is usually reserved for practicing physicians. She is working with the dean of the Usha Kundu MD College of Health to design one of the country's first specialized bachelor's degrees in respiratory therapy, which is expected to launch in Fall of 2025. 

How does ACCP advocate for you and how can you advocate for your patients and profession? Learn from ACCP's Senior Director of Government Affairs, John K. McGlew.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VGY865. CME/MOC credit will be available until June 4, 2025.Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Insmed.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VGY865. CME/MOC credit will be available until June 4, 2025.Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Insmed.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VGY865. CME/MOC credit will be available until June 4, 2025.Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Insmed.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VGY865. CME/MOC credit will be available until June 4, 2025.Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Insmed.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VGY865. CME/MOC credit will be available until June 4, 2025.Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Insmed.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/VGY865. CME/MOC credit will be available until June 4, 2025.Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: Ensuring Prompt Diagnosis Through Accurate Interpretation of CT Imaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Insmed.Disclosure information is available at the beginning of the video presentation.

CME credits: 1.00 Valid until: 15-03-2025 Claim your CME credit at https://reachmd.com/programs/cme/what-are-the-10-key-takeaways-for-the-2023-accahaaccphrs-guideline-for-af/19780/ The recently published 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines are based on systematic methods to evaluate and classify evidence and provide a foundation for the delivery of quality cardiovascular care. This program will help distill these valuable clinical guidelines to help healthcare professionals better understand these recommendations to incorporate into their clinical practice.

In this episode, we are sharing a discussion on the new guidelines for the diagnosis and management of atrial fibrillation (AF). Featured in this discussion are Brett Atwater, MD; Courtney Channels, NP; Pamela Brandt, DO; and Eric Sklar, MD, from the Inova AF Center at Inova Health System in Fairfax, Virginia.

CardioNerds Atrial Fibrillation Series Co-Chairs Dr. Colin Blumenthal (University of Pennsylvania Cardiology fellow) and Dr. Kelly Arps (Duke University Electrophysiology Fellow) join the 2023 atrial fibrillation guideline writing committee Chair Dr. José Joglar (UT Southwestern) and Vice Chair Dr. Mina Chung (Cleveland Clinic). They review the key takeaways from the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation.  Audio editing by CardioNerds academy intern, student doctor Pace Wetstein. This podcast was developed in collaboration with the American Heart Association. For more on these guidelines, access the AHA Science News AF Guideline landing page. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!

Coughs are one of the most common symptoms of childhood illness. But when should we start to get worried? What is a child's cough trying to tell you? Dr. Sunil Kapoor, a Pediatric Pulmonology Physician, joins Dr. Rebecca Yang and medical student Aparna Prasad to discuss the evaluation and management of chronic cough in children.  Specifically, they will:  Review the history and physical examination for a child presenting with a chronic cough Discuss the treatment for the most common causes of cough in children Evaluate the symptoms that suggest an underlying immunodeficiency Review the criteria for a referral to pulmonology Special thanks to Dr. Dionne Adair, Dr.Sunil Kapoor, and Dr. Rebecca Yang for peer reviewing this episode. CME Credit (requires free sign up): Link Coming Soon! References: Marchant, J. (2021, September 30). Causes of chronic cough in children. UpToDate. Retrieved June 2, 2022, from https://www.uptodate.com/contents/causes-of-chronic-cough-in-children?search=common+causes+of+chronic+cough+in+young+kids&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1    Chang, A. (2020, November 18). Approach to chronic cough in children. UpToDate. Retrieved June 2, 2022, from https://www.uptodate.com/contents/approach-to-chronic-cough-in-children?search=common+causes+of+chronic+cough+in+young+kids&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2    Gregory, S. (2021, May 4). Asthma in children younger than 12 years: Overview of initiating therapy and monitoring control. UpToDate. Retrieved June 2, 2022, from https://www.uptodate.com/contents/asthma-in-children-younger-than-12-years-overview-of-initiating-therapy-and-monitoring-control?search=chronic+cough+in+children&topicRef=91328&source=related_link    Pratter M. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):63S-71S.

Commentary by Dr. Valentin Fuster

In a landscape reframing with every churn of innovation and policy, 2023 presents a paradoxical blend of triumphs and challenges for corporate social impact, as observed by The Association of Corporate Citizen Professionals (ACCP). Transformation and resilience are themes echoed by leaders navigating the tempest of corporate citizenship, notably within technology sectors burgeoning with escalations in environmental, social, and corporate governance (ESG) considerations. ACCP, a consortium inclusive of ESG and corporate social responsibility (CSR) professionals from top-tier businesses, acknowledges this year's landscape as a testing ground where companies cannot "stand on the sidelines." The post Corporate Social Impact in Tech: Harnessing Resilience and Values Amid 2023's Dualities appeared first on ComplexDiscovery.

2023 ACCP Annual Meeting Recap Conference Correspondent: Anthony Hawkins, PharmD, FCCM, BCCCP Anthony's travel day, Dallas airport comparison and city review, poster hall likes/dislikes, unique and notable clinical sessions, favorite titles, Critical Care PRN business meeting highlights, award winners, FCCP awardees, correcting a last name mispronunciation, #MakePharmacyLessFormal and much more.  https://pharmacytodose.com/2023/11/22/2023-accp-annual-meeting-recap/ PharmacyToDose.Com  @PharmacyToDose  PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices

2023 ACCP Annual Meeting Day 1 & 2 Mini Recap Nick discusses his highlights, thoughts, and even suggestions from Day 1 & 2 of the 2023 ACCP Annual Meeting in Dallas, TX. https://www.accp.com/meetings/am23/index.aspx @PharmacyToDose PharmacyToDose@Gmail.Com PharmacyToDose.com Learn more about your ad choices. Visit megaphone.fm/adchoices

The Tweet/EMail : (7) Sarah Cummins (@SC_PharmD) / X (twitter.com) The Response: 8) ACCP on X: “In the latest President's Column, Elizabeth Farrington responds to member feedback from last month's “From the Desk of the ACCP President.” Read her response here: https://t.co/bkO52ztiHv https://t.co/hEUECYH1ib” / X (twitter.com) The post Episode 108. Discussing DEI, Transparency, and Advocacy in Pharmacy with Sarah Cummins and Kevin Astle appeared first on The Pharm So Hard Podcast.

CardioNerds cofounders Dr. Amit Goyal and Dr. Daniel Ambinder join Dr. Isabel Balachandran, Dr. Diego Celli from the Texas Heart Institute. They discuss the nuances of risk stratification management of intermediate risk pulmonary embolism. The ECPR for this episode was provided by Dr. Alam Mahboob (Associate Professor of Medicine at Baylor College of Medicine and the Department of Medicine and Associate Program Director for the Cardiovascular Disease Fellowship Program at Baylor). Audio editing by CardioNerds Academy Intern, Dr. Chelsea Amo Tweneboah. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media - Caring for the Middle Child of Pulmonary Embolism – Texas Heart Institute Pearls - Caring for the Middle Child of Pulmonary Embolism – Texas Heart Institute Submassive pulmonary embolism is defined as an intermediate risk group of acute pulmonary embolism, which presents with signs of RV dysfunction and myocardial injury without hemodynamic instability. The AHA, ACCP, and ESC have variable definitions of submassive PE. Non-invasive tools such as EKG, TTE, and CT are critical to defining RV dysfunction. The Pulmonary Embolism Severity Index (PESI) score is a validated tool to help risk stratify patients with PE. Advanced therapies for submassive PE include systemic thrombolysis, catheter-based intervention, surgical embolectomy, and mechanical circulatory support. The decision between these therapies is based on individual patient risk profiles, local expertise, and the risk of major bleeding. There is a spectrum of long-term complications after an acute PE, ranging from post PE syndrome to CTEPH (chronic thromboembolic pulmonary hypertension) caused by a maladaptive vascular remodeling from residual thrombus or arteriopathy. Thrombolytic therapies are still controversial in reducing the risk of post PE complications. PERT is a multidisciplinary group of clinicians who can rapidly assess and triage patients with acute PE, coordinate access to medical and advanced therapies, and provide the necessary follow up care. Show Notes - Caring for the Middle Child of Pulmonary Embolism – Texas Heart Institute How do you define “submassive” pulmonary embolism? Venous thromboembolism, which includes deep vein thrombosis and acute pulmonary emboli (PE) are the third most common cardiovascular disorder in the United States with approximately 900,000 cases occurring each year (1). The morbidity and mortality associated with pulmonary emboli are also great, with approximately 33% of PE cases being fatal (1).Until recently, PE was previously classified into massive or non-massive. Massive PE was defined as those with cardiogenic shock. A newer group, “submassive PE”, was defined as an “intermediate” risk group. According to the American Heart Association (AHA) Scientific Statement on the management of massive and submassive PE, patients in this group presented with signs of RV dysfunction and myocardial necrosis without hemodynamic instability (2). Intermediate-risk PE covers a broad range of risk and management decisions remain challenging. Intermediate-risk PE convers increased risk for mortality and complications compared with low-risk PE.  How do you risk-stratify intermediate-risk pulmonary emboli? The AHA, American College of Chest Physicians (ACCP), and European Society of Cardiology (ESC) have variable definitions of submassive PE and which biomarkers should be used (1,3). The contents are summarized as below (Table 1) Each major guideline highlights the importance of the evaluation of RV dysfunction (RVD) and elevated biomarkers. To summarize,

We are joined by two fantastic guests this week on the Faculty Factory podcast for a conversation on nonviolent communication. Drs. Cheri Lemieux Spiegel (Professor of English) and Paul Fitzgerald (Professor of Biology) together run the Annandale Center for Contemplative Practice (ACCP) at Northern Virginia Community College. The ACCP supports faculty, staff, and students alike, our mission is to foster a mindful and non-violent approach in their personal and professional journeys. Learn More This Faculty Factory Podcast Episode: https://facultyfactory.org/nonviolent  The Annandale Center for Contemplative Practice (ACCP): https://www.nvcc.edu/annandale/accp.html This Most Unbelievable Life: https://www.thismostunbelievablelife.com/ 

Podcast Summary: In this episode, Victor engages in a captivating conversation with Vera about breaking into the fintech industry and navigating careers as a young professional straight out of university. Vera provides valuable insights on the importance of career planning the 'Kingdom Way' and following God's plan for your life. She also shares valuable advice on staying rooted in your own culture and identity in the workplace while learning to love and accept others as they are. Guest Bio: Vera Okojie is a fintech consultant and accredited ACC and ACCP, transformational coach. As a valued member of a leading global fintech company's Consulting and Analytics division, she leverages her expertise to drive impactful solutions. Additionally, Vera is the founder of Career Confident, a community platform focused on empowering individuals to cultivate confidence in their careers. Through her coaching, she has guided and positively influenced over 100's of individuals, resulting in a remarkable £2 million+ in total client salaries. Connect with Vera: LinkedIn - https://www.linkedin.com/in/missveraokojie/ Instagram - https://www.instagram.com/career.confident/ Timestamps: (0:00) - Introduction (03:07) - Breaking into the fintech industry as a consultant (19:15) - Qualifying as a transformational and career coach through ACA and ACCP (28:21) - Exploring the meaning and importance of culture in the workplace (37:54) - Love as a transformative force in Vera's life (42:17) - Understanding true accountability in friendships (48:13) - Achieving over £2M+ in client salary impact as a career coach (54:04) - Leveraging processes and technology to systemise your business (01:03:33) - Career planning framework utilised in Career Confident business services (01:19:35) - Contrasting self-dependent career planning with the 'Kingdom Way' (01:25:43) - The pitfalls of seeking external validation and relying on commendation (01:29:40) - Vera Okojie's Three Valuable Tips (01:32:30) - Join The Valuable Community and Get Exclusive Merchandise ________________________________ Join The Valuable Community: https://forms.gle/svxzbheWKHgp4f8m9 The Valuable Community is the home for students and young professionals to connect and exchange value. Valuable Merch (Hoodie): https://b8d205-2.myshopify.com Newsletter/Blog: https://www.valuablepodcast.com Follow Valuable Podcast: Instagram - https://www.instagram.com/valuablepodcast/ TikTok - https://www.tiktok.com/@valuablepodcast Twitter - https://twitter.com/thevaluablepod Website / Blog - https://www.valuablepodcast.com/ Stream the Valuable Podcast: Spotify - https://open.spotify.com/show/2MDAvnLz3EeIaGZxtNVDAi?si=3399636fda774fa3 Apple Podcast - https://podcasts.apple.com/us/podcast/valuable-podcast/id1602872978 Google Podcast - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5hY2FzdC5jb20vcHVibGljL3Nob3dzLzYyNmMyZjcwNGE0Y2JlMDAxM2JlNTI3Mw?hl=en-GB

Kate is at the Cubs opener today, so you'll have to settle for Mark, Gary and Henry as they discuss reducing seizures in young kids, the best antidepressants for managing pain, and new ACCP guidelines for peri-operative management of anticoagulation and antiplatelet agents.

As the economy pressures companies to tighten their budgets, more ESG and CSR leaders are having to prove why their initiatives should remain a priority. Claims of “woke capitalism” from political leaders and a lack of internal consensus on ESG's importance only complicate the situation.ESG and CSR leaders are not alone, though. For 18 years, the Association of Corporate Citizenship Professionals (ACCP) has provided a network of support and resources to help professionals advocate for investment in ESG/CSR initiatives. ACCP cultivates inclusive peer communities to help members create a more equitable, sustainable, and prosperous society through corporate commitments.To share more about ACCP's work – and the state of ESG and CSR today – we invited Carolyn Berkowitz, President and CEO at ACCP, to the show. Listen for insights on:The difference between ESG and CSRHow to help educate colleagues in different departments about the importance of ESG/CSRHow to measure the “S” in ESG and extend it to corporate strategyWhen companies should publicly engage in ESG issuesThe skills needed for CSR employees today Resources + Links:Carolyn Berkowitz's LinkedInACCP CommunityACCP Membership (00:00) - Welcome to Purpose 360 (00:13) - Carolyn Berkowitz • ACCP (01:16) - Carolyn's Background (02:00) - Who Is ACCP? (02:26) - Generosity (03:34) - Why Become a Member? (05:21) - CSR and ESG (08:47) - Who's Doing It Well (14:16) - Challenges (16:12) - Dealing With 2023 (20:20) - Measure the S (22:34) - Employee Turnover Metrics (24:35) - DEI (27:37) - Dealing with Woke Capitalism (30:35) - Communication Practices (31:43) - Skills (33:53) - Last Thoughts (34:41) - Wrap Up

This week's episode features Kathy Pham, PharmD, BCPPS, senior director of Policy and Professional Affairs at the American College of Clinical Pharmacy (ACCP), who discusses her experience at ACCP and why advocacy is important to health care and the profession of pharmacy. Kathy Pham is the Senior Director of Policy and Professional Affairs at the American College of Clinical Pharmacy. Dr. Pham came to ACCP from the Pew Charitable Trusts, where she served as Senior Officer of the Drug Safety Project. Her previous clinical experience has been in pediatric pharmacy practice, with the majority of that time spent as the NICU clinical specialist and pharmacy residency director at Children's National Medical Center in Washington, D.C. Dr. Pham earned her PharmD degree from Rutgers and completed her pharmacy residency at the University of Illinois at Chicago. Dr. Pham leads ACCP's interprofessional stakeholder engagement to advance medication optimization.  https://www.brown.edu/news/2023-01-11/pharmacy-addiction-treatment https://www.genoahealthcare.com/pharmacists-can-start-patients-on-road-to-recovery-from-opioid-use-disorder-study-shows/

This episode is all about letters of intent and how to develop one that will standout. Questions we discuss:What is a letter of intent? How is it different from a cover letter or personal statement?What content should be included in a letter of intent?How can you be specific and avoid being generic in a letter of intent?What is "fluff" and how to avoid it?What other things should I consider for my letter of intent?This episode's take-aways:LOI is a short document that allows you to voice your career goals, experience and leadership that make you a fit for a residency program and also how the program can benefit youContent of LOI should be specific and should include: what interests you in the program, how the program can benefit you, how you can benefit the programLOI should be specific to each individual programFluff = generic traits a lot of applicants have (hard worker, manage time) - skills you think a resident should have that you just compile a listTo avoid "fluff" - provide specific examples as follow-ups when describing your attributes, skills or experienceMake sure you LOI showcases that you have done a great deal of self-reflection (about your experiences and skills and capabilities you gained from them) - this is important during residency trainingRead other examples and use your resources (mentors, preceptors, professional organizations [ACCP, ASHP], books, etc.)Make sure your LOI aligns with your CV and other pieces of your applicationDevelop a checklist of things you want to clearly articulateDon't write it in one sittingHave others read and double check your LOIAddress it to the correct program/program director Be yourself!Check out our website and sign-up to join the SASO (separate and stand out) squad. Check out our blog. If you like the show, support us by telling your friends or colleagues about it. You can also support us by clicking the coffee button on the website and buying us a cup of coffee or getting yourself some of our premium merch.Follow us on twitter @PGPharmacist or on Facebook, Instagram, or LinkedIn @ThePostGraduatePharmacist. What questions did we not answer? What did you think of the show?Music | "Sweet" by LiQWYD Watch: https://youtu.be/eIYlaVPdNYM License: https://www.liqwydmusic.com/how-to-use Download/Stream:

This episode is all about {}. Joining us is {}. Questions we discuss:What is a CV vs a resume?What goes into your CV?What are some ways to make your CV pop or give it some CV flare?What should the substance and focus of the CV be?This episode's take-aways:CV is much more than a resume. There is no page limit, and it's going to highlight your entire career when it comes to a certain profession. Your CV may only be 1 to 2 pages starting off, but it will expand. Your CV should be organized with clear transitions from one section to another. Section headers that stand out (bold, underlined) help people navigate your CV easily. Have your CV tell your story about your experience and education. Put things in reverse chronological order and label things, specifically dates, similarly throughoutNO COMPLETE SENTENCES! Avoid walls of text, you want this to be easily scanned and overall summarized. Don't go overboard with flare, but it is ok to add some color to make it stand out more. Consider having an online CV or online portfolio where you can show pictures or expand on elements in the CV. You can link the hard copy of the CV to the website with a QR code using a free QR code creator Check out some CV prep tips from ACCP and ASHPCheck out Episode 14, "Items to include on your CV" for more details on what to include and remove from the sections of your CV.What should you do now?Pull out your CV or resume and make the skeleton with the area's we talked about in the episodeSchedule some time every 3 months to update the CVCreate a to-do list of things to add to your CV and keep it What should you do later?Get others to review your CV, mentors, peers (peers you trust!)Continue to updateCreate plans for filling in gap areas Check out our website and sign-up to join the SASO (separate and stand out) squad. Check out our blog. If you like the show, support us by telling your friends or colleagues about it. You can also support us by clicking the coffee button on the website and buying us a cup of coffee or getting yourself some of our premium merch.Follow us on twitter @PGPharmacist or on Facebook, Instagram, or LinkedIn @ThePostGraduatePharmacist. What questions did we not answer? What did you think of the show?Music | "Sweet" by LiQWYD Watch: https://youtu.be/eIYlaVPdNYM License:

This week on Pharm5: SNPhA x ACCP Residency Showcase Amoxicillin suspension shortage Psilocybin for episodes of major depression RSV vaccine trials Walgreens removes speed metrics Connect with us! Listen to our podcast: Pharm5 Follow us on Twitter: @LizHearnPharmD References: SNPhA x ACCP Residency and Fellowship Showcase. ACCP. https://bit.ly/3fyqSrQ. Accessed November 3, 2022. Weixel N. FDA reports shortages of amoxicillin. The Hill. https://bit.ly/3fsEODL. Published November 1, 2022. Accessed November 3, 2022. Amoxil. Package Insert. GlaxoSmithKline; 2006. FDA drug shortages. FDA Drug Shortages. https://bit.ly/3UlvAb5. Accessed November 3, 2022. Goodwin GM, Aaronson ST, Alvarez O, et al. Single-dose psilocybin for a treatment-resistant episode of Major Depression. New England Journal of Medicine. 2022;387(18):1637-1648. doi:10.1056/nejmoa2206443 RSV vaccine protects babies from severe infections, Pfizer study finds. The Wall Street Journal. https://on.wsj.com/3UgNAna. Published November 1, 2022. Accessed November 3, 2022. Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate. https://bit.ly/3FFuh2v. Accessed November 3, 2022. Walgreens sharpens focus on patient care and experience, eliminating task-based metrics for Pharmacy Staff Performance Reviews Chainwide. Walgreens Newsroom. https://bit.ly/3t1TdcU. Accessed November 3, 2022. Walgreens will stop judging its pharmacy staff by how fast they work. NBCNews.com. https://nbcnews.to/3zGXvKA. Published October 28, 2022. Accessed November 3, 2022.

This episode of the HEE South West Advanced Practice podcast series explores the benefits and challenges for Allied Health professionals entering Advanced Critical Care Practitioner Training. The ACCP role can be viewed as predominantly a role for ICU nurses, however there are great advantages to the ICU team and AHPs undertaking this career pathway. In this podcast we explore how the previous skills, knowledge and experiences of a critical care physiotherapist and a senior paramedic provide a valuable foundation for ACCP training. We explore some of the myths, challenges and benefits of joining the ICU team in an advanced practice role from an AHP background. Host - Carole Boulanger HEE SW Supervision & Assessment Lead for ACCP, Senior ACCP and paramedic by background. Guests - Adam Smith, trainee Advanced Practice ACCP and Romain Lefebvre a Critical Care Physiotherapist. Connect with us: Email - advancingpractice.sw@hee.nhs.uk Facebook - https://www.facebook.com/nhshee/ Twitter - https://twitter.com/nhs_healthedeng Instagram - https://www.instagram.com/nhshee/ A transcript of this episode is available here.

Where do you see yourself in 10 years? The ACCP Resident Advisory Committee assembled a panel representing four career paths and advice on how to get there. This podcast focuses on how involvement in ACCP contributed to the panelists professional development. Moderated by Henry Okoroike, guests include: Deborah Bondi, Elias Chahine, Christina Doligalski, and Alexander Flannery. 0:00 – 5:58 Describe how you first became involved with ACCP. 5:58 – 10:10 How has your involvement in ACCP affected or directed your career path? 10:10 – 17:47 What was your path to becoming a fellow of ACCP (FCCP)? 17:47 – 24:05 What contribution to ACCP or clinical pharmacy are you the most proud of? Whether you are about to begin your postgraduate training or finishing it, you are certain to find some helpful advice. Watch the full video: https://www.accp.com/resandfel/advice.aspx.

Where do you see yourself in 10 years? The ACCP Resident Advisory Committee assembled a panel representing four career paths and advice on how to get there. This podcast focuses on career advice for the early practitioner. Moderated by Henry Okoroike, guests include: Deborah Bondi, Elias Chahine, Christina Doligalski, and Alexander Flannery. 0:00 – 8:08 Can you share some advice that made a positive impact on you early on in your career? 8:08 – 16:12 What advice do you have for trainees about continuing to be a well-rounded clinical pharmacist? 16:12 – 18:33 What is your advice for new graduates and clinicians desiring to get involved in research and publishing? 18:33 – 22:50 What additional advice do you have on work/life balance? Whether you are about to begin your postgraduate training or finishing it, you are certain to find some helpful advice. Watch the full video: https://www.accp.com/resandfel/advice.aspx.

Co-founder and CEO of Your Financial Pharmacist, Tim Ulbrich, discusses financial wellness for postgraduate trainees. He offers advice on debt management, investing, and protecting your income now and throughout your career.

Dr. Jerry L. Bauman, JACCP Editor-in-Chief, discusses key factors for designing, completing, and publishing retrospective research, like chart reviews. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1064.

Dr. Daniel Longyhore discusses the importance of postgraduate trainees disseminating their research.

Hopefully you matched in Phase 1, but what do you need to know about Phase 2 just in case? Learn from a colleague who has been through it.

The letter on the ACCP website was meant to be an example not a template for use in letters of intent. If you did use that letter, I have gone through it to raise the Grammarly score from an 83 to 100 and tightened the language, corrected the grammar, syntax, and spelling so you can if you really want to. Want my one-on-one help, go to https://residency.teachable.com/ or email tonythepharmacist@gmail.com 

Ten minutes of tips for presenting an effective virtual poster.

Corporate mandates have changed. Customers, employees, and even investors are increasingly pushing companies to move from shareholder to stakeholder capitalism. What does this look like across companies and sectors? Are companies moving fast enough when it comes to making good on their commitments to social change? Carolyn Berkowitz, President & CEO of the Association of Corporate Citizenship Professionals (ACCP), shares her insights, plus the importance of diversity and inclusion within CSR departments. Visit accp.org to learn more.

What impact has COVID-19 and the racial justice movement had on corporate social responsibility (CSR)? The Association of Corporate Citizenship Professionals (ACCP) partnered with Rocket Social Impact to research just that. Join Carolyn Berkowitz, President and CEO of ACCP, on today's episode to learn all about it and what motivated their research.   Topics Discussed in This Episode: What the ACCP does What motivated the research on the intersection of COVID-19 and racial justice What trends and data the research revealed on CSR budgets, importance to the C-suite, staffing needs Integration between CSR teams and other teams in companies (DEI, HR, ESG, Marketing) How to access the report: The Impact of Pandemic & Racial Justice Movement on CSR   Resources: Carolyn Berkowitz ACCP resources The Impact of Pandemic & Racial Justice Movement on CSR   Quotes:  “The expectations of CEOs and of senior leadership is significantly raising the game. They want to be reported to more frequently and want to have a greater hand in the [social responsibility] work.” “There's a heightened demand for measurement and there is not necessarily an increase in the internal resources to do that work… We've got to have the right people in the right places to do the volume of work that is expected and necessary to make change.” “40% of companies in the survey said that they are making a long-term CSR focus-area shift. 64% of those are shifting or adding racial justice and racial equity as a priority.”

In this episode, our guest is Dr. Leigh Ann Ross who is the Associate Dean for Clinical Affairs at the University of Mississippi School of Pharmacy and Professor in the Department of Pharmacy Practice. She previously served as the Chair of the Department of Pharmacy Practice and currently serves as Director of the Center for Clinical and Translational Science and Research Professor in the Research Institute of Pharmaceutical Sciences at UM. Dr. Ross also works with the John D. Bower School of Population Health at the University of Mississippi Medical Center as a Professor in the Department of Population Health Science. Dr. Ross received a Bachelor of Business Administration and a Doctor of Pharmacy from Ole Miss. She completed a Primary Care Pharmacy Residency at UMMC. Since joining the faculty in 2009, Dr. Ross has led practice initiatives to implement medication management services at the Medical Center and in communities through UM's Community-Based Research Program. In addition to her work in pharmacy, Dr. Ross completed a 2-year Congressional Fellowship in the Office of U.S. Senator Thad Cochran where she served as policy advisor on health care and also worked on labor, housing, and economic development. Dr. Ross is a graduate of Leadership Mississippi and has been actively involved in professional organizations at a state and national level. She is a Past President of the Mississippi Pharmacists Association and current President- Elect of the American College of Clinical Pharmacy. Dr. Ross is passionate about leadership development and advocacy within our profession. Key points: Service - I love professional service and I feel it is important to encourage our students and early career pharmacists to be involved in professional organizations. I have worked with most all professional organizations over the last 20 years, but my current focus is as President-Elect of ACCP and member of their Board of Regents. Leadership - I am passionate about leadership development. I appreciate the mentorship provided to me in this area and have tried to incorporate this into our curriculum for both students and residents. Advocacy - I feel advocacy to move pharmacy forward is very important. I have enjoyed building on my experience as a Health Policy Fellow and working with others to better understand legislative processes and how to advocate for our profession. Practice Advancement / Community-Based Research - I had the opportunity early in my career to lead the Pharmaceutical Care Clinics at UMMC, comprised of pharmacist-run clinics and interprofessional clinics and later to work with colleagues to implement a Community-Based Research Program to implement medication management services (like those in the Pharmaceutical Care Clinics) in community pharmacy and clinic settings. Through the Community-Based Research Program, we have established a number of partnerships, such as the Mississippi State Department of Health. Research - Most recently, I worked with colleagues to establish a Center for Clinical and Translational Science in our Research Institute. This Center is structured to facilitate research across the translational spectrum from basic research to clinical trials to communities. Our community research is now housed in this Center. Guest - Leigh Ann Ross, PharmD, BCPS, FASHP, FCCP, FAPhA, FNAP Host - Hillary Blackburn, PharmD, MBA www.hillaryblackburn.com https://www.linkedin.com/in/hillary-blackburn-67a92421/ @talktoyourpharmacist for Instagram and Facebook @HillBlackburn Twitter

On this episode of Leadership Lessons in Health-System Pharmacy you will hear from Professor Joe Dasta, as we discuss how pharmacy leaders can encourage their clinical staffs to be leaders within a specialty area of pharmacy practice. Professor Joseph Dasta received his B.Sc. Pharmacy in 1974 from West Virginia University, and a M.Sc. and residency in Hospital Pharmacy from The Ohio State University (OSU) in 1976. He began his academic career at OSU and developed one of the first practice sites and post-doctoral residency and fellowship programs in critical care pharmacy. Professor Dasta has trained eleven critical care residents and nine fellows; and many are prominent practitioners, researchers, and leaders in the profession and industry. Academic appointments include Professor Emeritus, The Ohio State University and Adjunct Professor, University of Texas School of Pharmacy. He is currently a health-care consultant in the area of acute care pharmaceuticals, including economic evaluations of acute pain management. Professor Dasta was a member of the Society of Critical Care Medicine (SCCM) council from 2007-2010. He serves on the editorial board of Annals of Pharmacotherapy. Professor Dasta has over 300 cumulative peer-reviewed publications, abstracts, brief communications and book chapters, with an emphasis on medication safety, acute pain management, sepsis, acute hypertension, hyponatremia, acute kidney injury, and pharmacoeconomics. He has also given over 250 lectures on various topics, related to critical care and health outcomes. His past honors and awards include: 2019 Clifton J. Latiolais Award recipient; 2018, the Weil-Shubin Master Clinician/Teacher Award, Society of Critical Care Medicine (SCCM); 2016 Master Fellow, American College of Critical Care Medicine (MCCM); 2013 American College of Clinical Pharmacy (ACCP), Russell Miller Award; 2010 Distinguished Investigator Award (SCCM). [First pharmacist to receive this award]; 2010 Sustained Contributions to the Literature Award, American Society of Health-System Pharmacists; 2005 Jerry Siegel Clinical Achievement Award; 2002 ACCP Education Award; 1990 Fellow, American College of Critical Care Medicine (FCCM); 1988 Fellow, (ACCP)

This week we are joined by Bobby Helmer, who is a clinical pharmacist and faculty member with experience interviewing and screening post-graduate candidates, as we discuss items you should and should not be include on your curriculum vitae (CV).   CV Review Services/Tool-kits: *https://www.accp.com/stunet/cv.aspx (ACCP On-Demand CV Review) (for ACCP members) *https://www.ashp.org/Pharmacy-Student/Career-Development/CV-Development?loginreturnUrl=SSOCheckOnly (ASHP CV Review Program) (for ASHP members) Follow us on twitter @PGPharmacist or on Facebook @ThePostGraduatePharmacist and leave us your comments or questions that we did not answer. Music by: @LiQWYD

In this podcast Gareth Thomas talks to Alex Scott and John Cully about the relatively new role of the ACCP and their experiences of training and working as an ACCP at Liverpool University Hospitals NHS Foundation Trust.

Dr. Aaron Devanathan provides perspective on advancing your research career via the fellowship or Ph.D. route. References: Bauman JL, Evans WE. Pharm.D.-only Investigators Are Critical to the Profession: Let's Preserve the Fellowship as an Equally Important Way to Prepare Future Clinical Pharmaceutical Scientists: Or the Case Against the “All-Ph.D.” Pharmacotherapy. 2009 February;29(2):129–133. https://doi.org/10.1592/phco.29.2.129. O'Donnell JM, Anand S, Brown SD, et al. Report of the 2018-2019 Research and Graduate Affairs Committee. Am J of Pharm Ed. 2019;83(10):Article 7595. Assemi M, Suchanek Hudmon K, Sowinski KM, Corelli RL. Educational Background and Academic Rank of Faculty Members within US Schools of Pharmacy. Am J of Pharm Ed. 2016;80(4):Article 61. Morbitzer KA, McLaughlin JE, Devanathan AS, et al. How-to guide for overcoming barriers of research and scholarship training in Pharm.D. and pharmacy residency programs. J Am Coll Clin Pharm. 2021;1-11. https://doi.org/10.1002/jac5.1426.

Tonight, is the Rubber Match (Finale) of our 2nd Great Cookoff staring Steve & Brandon. Battle Grilled Cheese will determine the winner and who will move on. Brandon has his movie review, Big EZ brought 2 all new beers to test and give a review on and Steve has our Top 5. Come hang out, we have plenty of chairs and we guarantee you will be entertained.

Round 2 of our 2nd Great Cookoff staring Steve & Brandon is Battle Spaghetti, who will prevail with their inner Italian? Brandon has his movie review of his weirdly connected but not movies. Big Ezy has a Top 5 for our enjoyment and as always, we have 2 all new beers to test and give a review on. Come hang out, we have plenty of chairs and we guarantee you will be entertained.

Baseball is back and so are we! Everyone here at ACCP hopes that you had an enjoyable Easter Holiday with your family and friends. Tonight, we have an all-new Millennium Movie Review with Brandon and his unofficial Marky Mark Week. We will review 2 all new beers and we have a very unique and personal Top 5.

ACCP Podcast for Residents by Residents: Dr. Monica Xi discusses careers in academia for residency trained pharmacists with Dr. Jeremy Daniel, Pharm.D., BCPS, BCPP, associate professor at South Dakota State University College of Pharmacy and Allied Health Professions. Reference: Young S, Vos SS, Cantrell M, Shaw R. Factors associated with students' perception of preceptor excellence. Am J Pharm Educ. 2014 Apr 17;78(3):53. doi: 10.5688/ajpe78353.

It's terrible to think about, but 1500 applicants who did not get an interview already know they will not match in Phase 2. What is troubling is that another 2500 applicants will learn, at the exact same time, they did not match. Here are my five steps for success in Phase 2 and where you can go for one-on-one help https://residency.teachable.com/courses The Five Steps to Take If You Don’t Match Introduction These are the five steps to take If you don't match. I am Tony Guerra, PharmD of the Pharmacy Residency Podcast. And I want to talk a little bit first about the emotional impact of the match and then how little time you have to take that next step. And I'll tell you why. And it has a lot to do with the numbers, but let's first take a look at that [match] day and how you might feel if you don't match. You're going to feel like you let your teams down, not just your college, but your friends, family, and everyone that has kind of supported you. Maybe you have an immediate family and you're married, have kids, all of these things. And you're going to have this feeling that you made mistakes and you didn't do well enough. You also are going to feel that you let yourself down. You worked hard, but in hindsight now you might be able to see some of the opportunities that you had, that you didn't take. And under the duress of all the work that you had to do, it was really, really hard for you to make the right moves and you weren't able to do it. The feeling is going to be one that your heart is going to be pulled out of your chest. The problem is that if you're going to apply for phase two, you have literally hours till the list comes out. And then just a few days until you have to get your application in to the next step, because when you go into phase two, the issue is that you have 2,500 other people that just found out that they didn't match - in addition to the 1500 people that already knew that they wouldn't match because they had no interview invitation. Now there are approximately 4,000 people that are going to try to either move into phase two or move into the job market. It's pretty clear the road will be difficult. I work out and do CrossFit and two of the people that I work out with sometimes are pharmacy supervisors. They've already seen the uptick in applications of students who want to quotation fingers, get back to the community,. This is really saying, “the residency thing didn't work out, I gave it a shot. I'm not going to try for phase two.” But many people will try for phase two and they have about 96 hours from just before the weekend to the next week. You have to get your application in, as soon as it opens because there is such a flood of applications that even if the residency sites don't shut their site down, they will stop looking at applications because they're going to have enough. As we move along it’s accelerated in phase two. It's more competitive, it's accelerated, and it's just tougher. Think about it as moving from a sport that was high school competition to now going to state or even nationals. You have to revise your letters of intent, articulate clearly why this site and how you match and you have to change around your CVs, especially if you're changing from [applying to] acute care to ambulatory care, ambulatory care to community, community, to ambulatory care or something like that. The order of your APPEs is the biggest thing where you need to have the most relevant sites that you went to at the top. Let’s say for example, that you had it in chronological order and you were applying to ambulatory care sites, but you put your acute care sites at the top, which may or may not make a lot of sense or your electives at the top, just because they were first in order. That's not what you want to do. The next thing includes the recommendations which I've talked about before. Not only do you have to let your recommenders know you're going to phase two, you also need to figure out if one of those recommendations or maybe more than one was toxic. Now it is absolutely the most painful thing to think that someone that you trusted did not give you a positive recommendation. But the question you have to ask yourself is, did you ask them if they would give you a positive recommendation? What is absolutely brutal, and this is one of those aspects I don't want to call a secret, but it's certainly something few talk about. Many times it is a faculty member at your own college that writes an honest recommendation. They're doing their job to write an honest recommendation, but the [unwritten] expectation is that if they are not able to write a positive recommendation after you spent a quarter of a million dollars on this education, it would have been nice for them to tell you, “I will write it, but I'm just letting you know that it would difficult for me to write a recommendation as positive as it might need to be for you to be successful in this residency search.” I have done that clearly articulating the nature of the recommendation and said, although you've done well, I don't think that the recommendation I will give will support you as well as maybe someone who came after me when you knew a little bit better what was expected [in rotation]. So, you have this very small window to get everything done and you need a team. I will be there from the time that everybody hears they didn't get it residency to the time where the application needs to be turned in. I'll be turning around letters of intent within 48 hours, usually sooner. And it's just going to be a matter of making sure that you know where your top site is, because what I do is I take that top site and help you make a letter of recommendation for that top site. And then I give you a template from that one so you can build your other letters and I can help you with those other ones if you want. But the fee for the course is for this one letter and if you want other ones, that's fine, but we can talk about that later. Right now, we need to focus on the team. Who are they? Whether it's your pharmacy fraternity, your college pharmily, or your friends. This may be the hardest thing for you to do, but you must let everyone know you did not match. If you do this quickly, it will be like pulling the Band-Aid off really quick or diving into a cold pool where once you get underneath the water, it’s fine. You must let everyone know you did not match because of what's going to happen with social media. The majority of the social media feeds are going to be filled with people putting pictures up of the that they matched and where they matched. But it is rare, and I mean one in a hundred or one in fifty that an applicant will l put up that they did not match. What applicants need to post, if they did not match, is that, “I need your help.” People cannot help you if they don't know you didn’t match.   What's going to happen when you tell a group whose primary responsibility is to help people that you need help? The first thing they're going do is reach out to you and, and try to help, and that’s what you need, from a little word of encouragement to a recommendation to them saying, “Oh my gosh. I can't believe you didn't match. Let's talk a little bit about what happened.” We might find that you applied to the top four sites and you only applied to four sites because that is what the initial application fee paid for. They can put a good word in for you, but they cannot help if they don't know. Let's talk about the five steps for phase two and how you should approach it. The Five Steps Read the Book I've written a book I need you to listen to or read. The phase two book will take an hour. It needs to be your first step. Don't start looking at the menu of sites that are open. Don't start doing anything that would take you down the negative road of what did I you wrong. Just listen to my advice for an hour on what you need to do and what phase two is all about.I assure you that if invest that one hour in listening to the book, it will make it a lot easier for you to get to where you want to go a lot faster. Identify Sites Then, and only then after you have that perspective, identify the sites in phase two that you are interested in. For example, you might live in a state where there might only be four or five available sites in that state. In general, there are around 200 spots. There were about 3,500 to 4,000 spots in phase. Of those, there's about 200 to 250 left. The issue is that there were 8,000 applicants for 4,000 sites and now there are 4,000 applicants, potential applicants, It's not that many, for 250 sites. So, the competition is much higher. Contact Sites Before the Application You must contact them about your interest. This is not an application. This is starting the conversation. Hey, I saw that you didn't have a match in phase two. I am also available. I just wanted to let you know that I will be submitting an application to you. Is there anything specific that I should know about your process and what you're doing? From these, you might get a conversation, but this is not a formal interview. You may get some informal interviews. Revise Your Letters of Intent, CVs, and Recommendations LOIs. You can send a past letter to tonythepharmacist@gmail.com to have me look at it and I can tell you in about five or ten seconds what the primary issues are and if I can help you. If you have a letter of intent that looks perfectly good, then it's something with your CV or your recommendations. But if I look at it and I see the UCSF template or the ACCP template, and I'm not going to judge you, but I'm just going to tell you that this is a generic letter of intent. We have a couple of hours to make this into a letter of intent that shows how you uniquely matched better to that site, better than anyone else. That's your goal. CVs. You need to, especially if you are changing from ambulatory care to community, community to ambulatory care, or acute care to ambulatory care, whatever it is, you need some revision, but maybe not as much as the LOI. Recommendations. And then the recommenders, you need to let them know right away. Hey, I'm going to need recommendations for phase 2. I want to go for it. Will you be willing to write a positive letter of recommendation for me? It is so important to put the word positive in because if they cannot, this gives them an opening that yes, I could write a letter of recommendation, but I don't feel that it would be positive at the level that you would need. And what that also does is tells you why maybe you didn't match in phase one. Immediate application. You must apply when the applications open at that hour. Crash the servers. Do what you must because there are literally hundreds of applications going to these sites that maybe before they didn't get a lot of applications. They're going to get them now because the numbers are so overwhelming. Again, it was 8,000 applicants for 4,000 spots. Now it's 4,000 available applicants for 200 spots - an order of magnitude different. Let's walk through these steps. Step 1. Read the Book – Expanded First we're going to get perspective and listen to a book about a student who matched in phase 2. The book is called Crushing the Phase 2 Pharmacy Residency Match: Proven Tactics to Earn a Clinical Pharmacist Training Position. Before you can even start this process, you first need to believe, and I know that's cliché but you can match in phase 2. eBook If you have Kindle Unlimited, you can already get the eBook for free. It's part of your Kindle Unlimited. I have made it that way so you can have access to it. It's like 10 bucks if you get the eBook without Kindle Unlimited. Audiobook If you've never been on Audible.com before, you can get on and get this audiobook for free, or you can email me at tonythepharmacist@gmail.com. I have 20 free codes left. I've given a couple of them away, already to people that have asked me for them that know that they didn't unfortunately get an interview opportunity. But, I do have a couple of free codes left. I don't think it's expensive though. I think it's like $5 or something like that, but it is under $10 to get the audiobook. But what I need you to do is not only understand how phase two works, but I need you to hear a story about someone who did it, and this is the key. They matched in an academic medical center, one of the toughest residencies to get. Parts of the Book There's an introduction explaining the numbers from a year ago because it takes so long to write a book like this and get it published in audio format, but the information is still relevant. You will learn about match day, the four day weekend, 96 hours when phase two opens for applications and how you use match statistics to inform your application. So, if you're coming from a school that matches well traditionally, then phase two sites are going to be very excited about your application. For example, if you’re at Kentucky or UNC or Drake or Iowa or Minnesota, or UCSF and someone sees your application, then they will look very favorably on your application. Are they just going to look at your school? Imagine if you got 200 applications in a single day and you have four residents and yourself who thought the process was over and now you and those four residents need to somehow evaluate 200 applications. What's the very quickest way to do it? Look at the top schools. Dr. Key Gales, who worked for me for a couple of years helping as a college teaching assistant matched  in phase two, not only in PGY-1, but in phase two of PGY-2. It's a story about someone who was well qualified, who did something that is very difficult to pull off. He applied to acute care sites, being very honest about his goal to be an ambulatory care. But I think he actually ended up wanting acute care after he began his residency. He matched to a highly sought after academic medical center, which is hard enough to do in phase one, which is nearly impossible to do in phase two. And I don't think that if he didn't come from Drake, one of the top schools in that year, I don't think he would've had a chance. But he was a Midwesterner coming to a Midwest site and I'll talk more about location later. And then there's a chapter about another book that I've written called Finding Your Unicorn Job for Pharmacists: Financial Freedom, Flexible Hours, and Personal Fulfillment Beyond the Pharmacy Counter. The misconception is that a unicorn job is when there is only one of them. And what I am really saying is that it's a job that you create because it's exactly a perfect fit for what you want. But again, I made the Crushing Phase 2 Book intentionally just an hour so that you can get through it on the drive home. Step 2. Identify Sites Expanded The first thing you want to do is get your head around is that this is a people game, not a qualifications game. When you have 200 people applying for the same spot, that means that the director needs a way to sort it out. And I've talked to RPD after RPD, and they all say the same thing. It doesn't matter what we do with the rubric. Everybody's a couple points from each other. We need to know people and we need some kind of connection. Sites Where You Know People The very first place you want to go is where you know someone or where someone, you know, knows someone. And this is where it becomes so important that you were in an organization, especially if you were in a leadership position. And from that leadership position, you can reach out to other people. If you did an APPE at the site, you've already done a five-week interview and you can let them know, “Hey, I didn't match. Are you open to an interview?” You can communicate with them and get that started. But also, you can speak to your faculty, and say, “Hey, you know, I didn't match.” And they will help not just because it looks better for the school if extra students match, but because they genuinely have been building you up and developing you and they want you to succeed. In-State Sites, then Regional, then National I would definitely prioritize sites in your own state, then sites in your own region and then sites nationwide - in that order. It is really hard in phase two with the speed that all of this happens for someone in the Southeast to articulate their value to someone in the Pacific Northwest or someone in the Southwest to articulate their value to someone in new England. You have to build that relationships. Maybe with APPEs or through connections, but you might be in a state that has only one or two available spots and you'll expand to your region. And then from that region, you'll go nationwide. But again, we are going to start talking about contacting sites because the process really is going to start happening the day that that notice goes out at noon. Step 3. Contact sites before application day. One. Sites often schedule informal meetings before the application day, but they cannot accept your application, that has to go through PhORCAS. Don't think that good places aren't in phase 2. Maryland was in phase 2, which gets easily 200 applications per position. Cleveland clinic was in Phase 2 last year. There are many, many very good programs in phase 2. And they are there because they didn’t need to rank everybody that they looked at in Phase 1, because they know that there's going to be plenty of good applicants in phase 2. Yeah, it's going to be a pain, but they know that the quality of their residents will remain very high. Two. An email of interest that allows you to see which sites are receptive to you. They really want to hear from you and this may sound strange, but you're going to be thinking, well, I don't want to bother them if they're going to have all this volume. Well, what needs to happen is that you need to contact them, make the application, and then build a relationship and you have to do this very quickly. I have heard of students emailing 30 or 40 sites and actually hearing back from maybe half that, 15 to 20, and then making applications to those where they got a positive response. And what that does is it halves your work, instead of hoping that these sites are going to be receptive to you, you're going to find the sites that are actually receptive to a quick email back saying, “I definitely think you should apply to our site. I think we're good fit.” Here is best practice. You should attach and put your information in the body of the email. I remember when I was hiring during the housing market crash and I was still running a real estate practice. Because there were so many real estate agents going out of the business, I had plenty of work to do, and I was hiring, but I was getting all of these applications. And what I would find is that maybe they application was in Pages, which is Mac or Apple's word processing program. I couldn't open it because I had a Dell at the time. Now I have a Mac. Make sure that you put a relevant part of your cover letter or CV in the actual body of the email. So that instead of that need for an extra click, the director can quickly scroll down and immediately and see, “Oh, wow, they've got a bunch of these rotations that they've done at nearby hospitals. This person might be a really good person to interview. So again, attach and put the same information in the body of your email. Step 4 Revise LOIs, CVs, and Recommendations – Expanded LOIs This is the book I've written it, The Strong Residency Letter of Intent: Writing to Be Interviewed with a Cover Letter that Earns the Invite. You must revise your letter of intent. The LOI is not why you are the best, someone will always have more qualifications. This is the number one reason that someone did not get an interview. They are trying to win a marathon against a marathoner and they are a 5k runner, or they don't work out much at all. There is always going to be someone more qualified. What you must do is match them best and show how you are the best fit that the marathoner may not be a very good fit with a group that likes to play hockey. And I'm just making up some sports analogies. Show don't tell how you match. Let's say there's a Children's Hospital that has an opening available. And you say, this is a story about my experience in the PICU. And I want to talk about the PGY-2 rotations that you have that are really something that I would love to build on the experience that I had in the PICU. That is showing why you are qualified. What is telling that you are qualified is to say “I want to do pediatrics.” The big thing with this phase 2 is making sure that you are able to show them quickly in a scannable document. What that means is that the most important thing is in the first couple of sentences that you are writing a unique letter to them. You cannot pull off a generic LOI in phase 2, it's just not going to work. The Illusion of Explanatory Depth. A letter of intent is, and when you wrote it the first time you may have just taken a template, written a letter, made sure the grammar is right and sent it in. It's just a letter about you. It should be really easy. This is the illusion of explanatory depth. So why is it so hard to write a good letter of intent? And this is an excerpt from the Strong Residency Letter of Intent Writing To Be Interviewed With A Cover Letter That Earns The Invite. Here's a nerdy answer. Can you tell me how a microwave works? You'd probably say sure, but then when i asked you to give me a detailed explanation with drawings, you would really struggle. This is the illusion of explanatory depth, which basically says, most people think they understand something better than they do until they have to explain it to someone else in detail and I should have put after that “or do it themselves.” We need to write a cover letter that tells us about your past, about how your experiences match the site’s offerings. We need you to do it in a single page and please use 11-to-12-point font with one-inch margins and proper business formatting, making sure to double space between the paragraphs. Okay. Got a little harder. Right? So, when you try to write a letter of intent, you are the victim of this illusion. You've written emails, papers, maybe a resume or CV, but properly crafting a letter of intent that earns you an interview takes a specific skillset that you likely haven't honed. It's not that you couldn't do it if you were given enough time, but in 96 hours, you have to write maybe 10 letters. That's why people come to me because what I do is I help them write that first template, the perfect unique template to them, to that first site. Then I helped them with the template for the second through 10th letter. While the people I'm working with are banging out those letters, no problem, getting them done and moving on to the CV and recommendations, fine tuning their emails to those people that they want to talk others are wondering what went wrong with their letter. I've read hundreds and hundreds of letters. It takes me seconds to figure out what was wrong. And it takes me a little while longer to make it right, but I assure you that I can. And if you've not worked with me before you just go to residency.teachable.com/p/extremeLOI and sign up for the course, email me your letter and CV and first choice residency and we will be off and running or contact me at tonythepharmacist@gmail.com. I mentioned this before, you must prioritize the rotations they offer in the APPEs you match to. You don't have to list APPEs chronologically, which often makes no sense. And if you're listening to this on audio and can't see the image here is the image of someone who doesn't seem like they didn't match. They're relaxing on their backpack, on a beach, just typing with the waves in the background, what you want to do as you're doing the CV is relax. As you're writing the letter of intent is acting as if you are going to match and that if you don't match, no problem. It's a very tough feeling to pull off. But what you want to do is not write this in this frenzy. What I hear over and over again from the people I work with is that “I feel so much more confident. Now my anxiety is so much less. Now, at least I know that I did the very best I could in this area.” There are no guarantees or anything like that, but what I can do is change the feeling that you have from one of scattered, chaotic confusion, and lack of confidence for a better term, to a confident, well-articulated argument that you match to. If you can't see the image, it's a soccer coach talking to a group of kids sitting down and showing the game plan. You want to gather your recommenders and game plan with them. They will fight for you if they really liked you and they want you to succeed. They will make the calls for you. You never know if in the background, someone called someone to say, “Hey, I think you should really take a look at this person. I know that they're going to apply.” Okay. What, what was the person's name? How do you spell that last name? Okay, great. And you say, no, that really doesn't happen. I assure you. It happens all the time. Pharmacy is a small world. We know a lot of people. When you have a preceptor and especially if they're in a specific field, they have an even smaller group, but they can let you know about some opportunities that you may not have heard of, or that are coming up. But again, the network, the organization that you have put your time into, that's where you really want to go and make sure that the recommenders know what they need to do. Apply on the first day - Expanded Even if the sites don't formally close, the sites will stop taking applications. They will stop answering emails. If you've ever been in a community pharmacy where maybe two people called out and you don't even have time to answer the phone, it’s like that. You must apply on the first day and early in that first day as many Phase 2 sites have never done Phase 2 before. Let's use the number 200 if 4,000 matched. Okay. That means that only 5% of sites would not have matched in the past year. And I know that this math is not exactly right, the way that I'm doing this, but that means that if we had 4,000 sites every year, and if every year, 200 didn't match, that means that it would take 20 years between times they didn't match. It is at least a rare event that Phase 2 sites have not matched. So, when you say, gosh, they seem really disorganized. What you want to do is provide the solution. Let me help you. Let me tell you why I can solve your problem. Let the other applicants go. I am your solution. Obviously. You're not going to write that, but that's what you've got to think is that, Oh, wait a minute. They're really struggling, they've got to scramble to get the interviews in, to get this job hire person hired, because if they don't get hired, the institution may cut that person from the budget. The volume is absolutely overwhelming on their side. In this last part I want to talk about a sports analogy. And I don't want to call it little league because it's soccer, but my daughters are nine years old, and they've been very successful in soccer. And the reason is because of a small shift and a single book that I read, and yes, I've been coaching them. But when we started this and I mentioned this in the number of my books, I was not good. We lost games, a lot of games. We only won a few. And I said, okay, well, this is my fault. Let's see what are the things that we can do? And I became a student of soccer so that I could serve them at the highest level. Now I'm going to help you become a student of the Phase 2 process and how to do this in such a way that you can maximize your chances. The book on soccer, the book is from Dan Blank, who was a Division I coach for a little while, but his fame actually came from being, I think, an NAIA coach where he clearly articulated what the things are that a student of the game would need to know. And I'm going to tell you three of those things and how they relate to the residency process. The Holy Grail of Soccer and Phase 2 -  Speed of play where everything is faster to tactics. We'll talk about the 50/50 throw-in ball and odds as you have to know where you stand based on your college. And if you're applying in-state / out-of-state and all of those things to know how many applications and where to apply Right place, right time. The kids used to wear wristbands. And I bought them these wrist bands where blue would be the strikers pink would be the midfielders and then white would be the defenders or backs. What we would do is we would set it up in such a way that they would know exactly where they need to go and we would make these shifts as we're transitioning people in. And they would know exactly what their role is as they went in, because they were getting this wristband now in COVID. We couldn't do it. But again, that's, the approach that we took. Let me talk about the Strong Letter of Intent Book excerpt, as I relate to speed of play tactics and being at the right place and right time In applying for residency, you don't realize your speed of play is not up to par until a professor rejects your recommendation requests, because she has too many already. When you spend weeks on your CV compared to hours on your letter of intent and recommendation, your tactics are off. The LOI and recommendation letters count much more than your CV and four years of school. When you try to talk with the residency director during the mob, that is the residency showcase you're not meeting in the right place and right time, meaningful conversations happen at the evening, relaxing state and college gatherings later in the day, I don't want you shut out. Like my team was in that game. I want you to be a member of the team to beat. You have to increase your speed of play, study, successful tactics, and put yourself in the right place at the right time. Speed of play: Take everything you do and do it faster In soccer. I remember this game so clearly, and I remember the other coach screaming at the ref, and there's nothing I could have done. And the ref couldn't hear him. My daughter was so fast at getting the throw in and throwing it in that she no longer cared if it was our throw in or the other teams. The ref, it was their very first time refereeing a game, but she didn’t stop my daughter who just kept throwing it in for us. This coach is just screaming and there's nothing I could do. Because everyone in the team knew where the ball was going to go, they didn't have to bother setting up. They were already running towards the goal. The other speed of play aspect, which is a little bit tougher, and this is really more when you're kind of getting to 9 and 10 year olds and maybe 11 year olds is the one touch pass, where the ball comes to you and you don't sit there and wait with it, kind of look around and then make a decision. But rather you've already made the decision as the ball is coming to you. And in one touch, you make the pass so that the defender can't attack you or tackle you. In residency, you must apply on day one of phase 2 and you must communicate before the application turn-in day. That is an increased speed of play. You are talking to them beforehand. You are not waiting, hoping that you’re going to submit the application and cross your fingers and hope for the best. You are an active person, making sure to lean into your network and to talk to those people ahead of time and apply on the day. Tactics The picture is actually the daughter that does the throw in thing. I became a student of the game and I found out that in soccer, throw ins are a 50/50 ball. That is whether you are throwing it in towards your team or not, you will lose the ball fifty percent of the time. In such a short field, if you throw it at their goal, instead of throwing it back to our goal, to maybe one of our players, to bring it up the field, you have not only gained 15 feet towards the goal, but not lost an additional 15 feet towards our own goal. In residency, you must apply to local versus national first. That's your best chance where you have relationships. You want to apply where your pharmacy school has had historical successes. Some pharmacy schools traditionally have sent many, many students to residency. I've mentioned this before, but the top 10 schools send 500 students to residency. That is an order of magnitude of 10. If your school is at the bottom, you know that you must increase the number of applications and you must apply locally. You must increase your connections to the people who are making the decisions. If you're in the top, you must lean into the network. Take advantage of that. And hopefully you have a local site to apply to. Right place, right time. Position yourself for success In soccer. The shape must change in offense and defense, and it was completely my fault, but we lost the game because of just this tactic. When you are in offense, your defenders should be spread out and should be up closer to the midline which is the second image on the right. If you are defending, you should contract and you should both be really at the top of the goal box. For  about six minutes of the game, I had wwo players that thought they were wings and not defenders. And it was up to me to clarify that and clear it and figure it out. And I didn't, and we lost the game by one, but in that six minutes, the other team scored four goals as they just attacked right down the middle, right down the middle. We just opened it up that lane for them because we were in the wrong shape, in the wrong position. Local equals less risk for the residency site. And for the applicant, if they know you're from around here, then you'll probably stay around here, and it'll be a better deal. How do we start? How can I help? I have helped almost 200 students this season, in just this season. So, we're talking that of the entire national applicant pool to residency this year. I have helped 3% of that entire group. I will be helping students with letters of intent all weekend from the time they find out where to the time that you need to apply, I will be returning those letters of intent within 24 to 48 hours. People ask, well, how many revisions do I get? You don't need them. I'm a PhD level trained English, major undergrad has done master's work and PhD work in English. I have taught Composition I and Composition II and Comp II is most important because it talks about the arguments and logos, ethos, and pathos. That is what you're really doing is making an argument as to why emotionally, logically and through evidence that you should be the one that matches. Go to http://residency.teachable.com/p/extremeloi It's $95, if you want to work with me. And if you are PDC, please let me know because a portion will be going to national. That's a new thing, but I just want to let you know that if you are a PDC, please let me know when you send me your old letter of intent and your CV. I will always look to see. So even if you don't tell me, I can see if you were the worthy prelate or in another position. LOI Course But it is $95 if you want to work with me, but I assure you that turnaround and the quality that you get. Ask somebody who's worked with me as I've worked with so many people. There's probably someone at your school that have worked with and my track record speaks for itself in terms of success. I have had a student I've worked with who has, I believe, 15 interviews and another one, who was perfect, getting interviews at all the places they applied. While I can't guarantee that you will get the residency position, I can guarantee that it will be the best that you can possibly do given the amount of time. And it will be a very high-quality letter, but that is my specialty. I can look at CVs and things like that, for an additional charge, but I I'd really recommend you use me for the letter of intent. I'm good at grammar and syntax with CVs and seeing what needs to be where, but in terms of formatting, that's just not my thing. Interview Course And then if you do get an interview, I do have an interview course, residency.teachable.com/p/ interview that will, in three hours, explain the point system to you. So, if you did have interviews and you asked, “Why didn't I match?” With the interview course you get up to six months of email support from me. So, if you have questions like this is my thank you email, is this grammatically correct? And I'll say, okay, well, no, it's not. Here's what it should be. And then I'll help fix it for you, or I'm trying to rank these. Can you help me with the rankings? Yeah, sure. I can do that for you. Past Interview Review If you want me to do this, and I only do this for a couple of people for $295, I will listen to up to an hour of your interview that you have had or a half hour of interview questions that you will answer. And I will provide my feedback on what happened, why didn't you match with the answers that you had. But again, that $300, that's kind of a premium service. I only do it with a dozen people. If you really want it, I'll do it. I do enjoy it, but again, I know that's a lot of money for someone that just spent a couple of hundred thousand dollars, but again, the payoff is of course, hopefully getting, the residency in Phase 2 but sometimes the easiest thing to do is just email me: tonythepharmacist@gmail.com. Sometimes it might just be easiest to just contact me with a question that you have, and I'll let you know if I can or can't help you. I apologize if you're emailing me during that busy time. I'm going to prioritize those that have already enrolled in the course and that have sent me their letter of intent and CV, but I'll try to do my best to help you, but the volume is immense during that weekend. and I've cleared my schedule for that so that I can honor that promise of returning a high-quality letter to you within 24 to 48 hours. But if you have a question now has been a better time to ask me at tonythepharmacist@gmail.com.  

Today I do a quick review of the COVID-19 thrombosis literature from the last year to try to answer some of the following questions: Why does COVID-19 cause thrombosis? How many patients with COVID-19 develop thrombotic complications? Why do patients with COVID-19 on VTE prophylaxis still develop blood clots? Should we use intermediate dosing of anticoagulation for prophylaxis? What about full dose therapeutic anticoagulation (no!) What do the guidelines say? Lots of papers:JAMA IM Review Autopsy Findings and VTE in Patients with COVID-19Klok et al Helms et alShah et alPiazza et alPorfidia et alKunutsor et alDutt et alStessel et alParanjpe et alFraisse et alMusoke et alPatel et alISTH GuidelinesACCP GuidelinesTake home points:COVID-19 is associated with an elevated risk of thrombosis. Observational data suggests that ICU patients are likely to develop thrombotic complications even on standard VTE prophylaxis. This number seems to be round 25%. Ward patients are also at higher risk (around 8-9%). Critically ill patients commonly develop heparin resistance, and this may partially explain why some patients with COVID develop thrombotic complications despite prophylaxis. Some have suggested intermediate dosing of anticoagulation for prophylaxis, but there are no randomized controlled trials published at this time, and observational data are limited. Some have suggested therapeutic dosing of anticoagulation for critically ill patients, but observational data show high rates of bleeding and other complications, and the three largest randomized controlled trials have stopped enrolling critically ill patients into the therapeutic anticoagulation arm due to safety concerns and futility. Some have suggested targeting a certain anti-Xa activity level, but no one really knows what that should be, and there aren’t any guidelines recommending it. ISTH and ACCP have both put out guidelines which are overall pretty similar.Make sure your patient has VTE prophylaxis, preferably a LMWH, and keep an eye out for thrombotic complications so you can treat them in a timely manner. Music from https://filmmusic.io"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)License: CC BY (http://creativecommons.org/licenses/by/4.0/)

In this episode Laura Whitehead interviews Tim Kuhn. Tim is a Critical care nurse who is currently finishing his training as an Advanced Critical Care Practitioner. Tim discusses his career to date, his advice for newly qualified nurses wishing to work in the intensive care unit and the training he has undergone on his ACCP course. He gives an insight into Flight nursing and discusses the work he does with St Johns Ambulance.Visit @navigatingnursing on Instagram and @LauraWh56878961 on Twitter for podcast updates

2020 ACCP Annual Meeting RecapSpecial Guest: Anthony Hawkins, PharmD, BCCCP Reference List: https://pharmacytodose.files.wordpress.com/2020/11/2020-accp-annual-meeting-references.pdf 06:30 – Virtual v. in-person meetings; 30:35 – BIG announcement!; 34:15 – Poster sessions; 47:00 – Scientific sessions PharmacyToDose.Com@PharmacyToDose on Twitter/InstagramPharmacyToDose@Gmail.com

Today’s ‘Transforming a Nation’ Podcast episode 5 in the series, focuses on ending the inexcusable Sexual Harassment in the Profession of Pharmacy. Our host of this episode is Dr. Rebecca Smith @RebeccaESmith on Twitter, who started bringing massive awareness to this reoccurring issue.  See tweet here:  https://twitter.com/rebeccaraesmith/status/1308161152988270592?s=20 Rebecca's guests are always testifying about their experiences with Sexual Harassment in pharmacy, including Brooke Barlow, PharmD who's a PGY2 Critical Care Pharmacy Resident at University of Kentucky, Ashley Barlow PharmD PGY2 Oncology Pharmacy Resident at MD Anderson Cancer Center, and Jackie Johnston, PharmD a Surgical Trauma Neuro ICU PharmD & Clinical Assistant Professor PGY-1 RPD.  References: Addressing Sexual and Gender Harassment in Pharmacy Education to Improve Provider Wellness and Patient Care https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223926/ Frequency and severity of sexual harassment in pharmacy practice in Ohio https://pubmed.ncbi.nlm.nih.gov/10533349/ This episode is sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast  See omnystudio.com/listener for privacy information.

KMF is an organization founded by aspirator and main architect, Rev. Dr. Kay Morris. She is a multi award winning Grammy Considered, International Reggae Gospel Recording Artist; she is also an Ordained Reverend and Bishop. Kay Morris' musical work preceded her in Africa; while she was on tour in Ghana and Nigeria, she saw the plight of the marginalized children and women and decided to use her gift of music to advocate against poverty and HIV/AIDS. In 2004 she carried out her first mission to West Africa. She uses her music as a fund-raising tool for her charitable causes; as well as a platform to raise awareness and make a difference in the lives of children orphaned by AIDS in Africa. She speaks at many youth and women empowerment conferences and is a mentor to many youths in Canada, Africa, Jamaica and other parts of the world. In 2006, Dr. Kay Morris brokered $1.5 million dollars in anti-retro viral meds for people living with HIV/AIDS in Sub-Saharan Africa. She was enstooled and given a Royal Title Queen Nana Oye Sika I in Ghana, in honor of her humanitarian work. Kay Morris holds an Honorary Doctor of Humanities Degree and an Honorary Doctor of Divinity Degree. In 2019, Dr. Kay Morris received the UN ECOSOC World Excellence Sustainable Development Achievement Award and was appointed as UN Peaceful Ambassador to represent the ACCP at the UN Headquarters. Kay Morris is alsorecipient of other prestigious awards such as: Nelson Mandela Humanitarian Award, Nelson Mandela Memorial Award and BEFFTA Global Humanitarian Award. www.kaymorrisfoundation.com sponsor by www.tradeacademypro.com take advantage of our 30 day free trial. You can donate to the show or purchase a book at www.momentspod.com --- Support this podcast: https://anchor.fm/momentsofgrace/support

We are joined by Dr. Hannah Gibson, PGY1 resident at Huntsville Hospital. Evaluating programs is an essential part of the application process. Not only will it give you a better idea of what you are looking for in the program, it will allow you to generate questions to ask that program. Ways the evaluate programs:Talk to programs at showcasesTalk to graduates of the program (when available)Review directory listing on ASHP residency directory or ACCP residency/fellowship directoryReview program websiteReview institutional website where the program is housedShowcases:We address these in another episodeReview Residency Directories:Directories are sometimes a hit or miss. They will often be outdated and not contain relevant information about the program. The directory listing should really serve as the abstract or trailer for the program. You should be able to determine from the directory listing if the program is worth further investigation. If it is, then go to the programs website (if it even has a website). Review program website:This is generally where most of the information about a program is kept. You can find a lot of information about the design and experiences of past residents. Here is what you should look for when reviewing a website:Preceptor qualifications - are preceptors certified in their field of expertise (i.e. BCPS, BCACP, BCCCP)What types of rotations do they have?What types of rotations are required vs elective? - Look for variety here. If several of your must have rotations are listed as electives, it's not guaranteed you will be assigned to each one. Look for things like cardiology or critical care rotations as required vs elective. Also look for things like medication use evaluations and project months. These can be good, but if the majority of rotations are these filler rotations you may not get as robust of an experience. Who are the current residents and what are their qualifications?Who are the past residents and what are they doing now? - a huge indicator of the caliber of program is what the residents are doing after. What sort of careers does this program allow you to completeInformation concerning funding and travel - do they pay for you to attend midyear? Mentorship - is there an assigned mentor, is there a research mentor?Number of residency positions - do you like a small class or large residency classThings to look at, but really should not make or break the program for you:Staffing component, do you staff, how oftenSalary - lets face it, the salary is going to be around 45-55k a year based on cost of living. It is most likely more money than you have ever made before, and it is only 1 year, afterwards you will be making significantly more (unless you do PGY2).

BLACK NICHOLSON - A well-known and highly regarded fixture in the Atlanta entertainment Industry over the past 25 years, Mr. Nicholson is involved in all facets of the business from onstage to behind the scenes. Black has worked in all areas of the music industry from BMG/Sony street team manager to Major Label signed recording artist, to Artist Manager handling six figure budgets, to owner, and er and operator of The Omen Agency, a full service booking agency, production company and venue based in Atlanta, Germany, Lagos and Johannesburg. Most recently Black secured a historic deal for singer-songwriter Tina P.  Black Nicholson, has also hosted and co-creator of "What It Be! This week in HipHop" a highly entertaining Radio show on S.A.'s 5FM that looked at the US scene, while interweaving local artists and news throughout Africa and in UK. Mr. Nicholson has also expanded into the film sector. Jermel Howard, Angelo Diaz, and Markice Moore are apart of Black’s client roster (see links below). • The Omen Agency is a full service Marketing, Promotions, Production, Booking company and venue based in Atlanta, Germany, Lagos and Johannesburg. We exercise a worldwide vision with you in mind. Our facilities include a record company, a fully staffed marketing team, a digital/physical distribution company, and a multi-media entertainment firm equipped with a team of agents and sales associates at your disposal. At The Omen Agency we develop entertainers from start to finish all under one roof. Keep an eye out for the Omen Agency, “A sign of things to come” • The Omen Agency takes Rick Ross to South Africa: https://m.youtube.com/watch?v=71fhLXeWuxY Omen Agency In-House Endorsements: https://m.youtube.com/watch?v=tSOzTFEqc88 #FUPCancer Birthday Bash: https://m.youtube.com/watch?v=S53-pa0Pw3I#searching https://m.youtube.com/watch?v=XcqKe-6N07g   OMEN AGENCY CYPHERS, R&B Nights, etc: https://m.youtube.com/c/TheOmenAgencyAtlanta/videos?disable_polymer=true&itct=CBUQ8JMBGAEiEwiZm52_-MLqAhUCHWQKHcoRBOI%3D&disable_polymer=true&rootVe=3611&disable_polymer=true&rootVe=3611&disable_polymer=true&rootVe=3611 •  Tina P’s “i Think i Fell” ft Stand Up In It Man Theodis Ealey.  Click the FREE “DJ PACK” link at the bottom of the page.  It contains the clean, inst, & Accp. Give the Family my love. ENJOY! http://go.iamtinapittman.com/album/i-think-i-fell/ • JERMEL HOWARD (ACTOR/DIRECTOR): Jermel Howard was chosen for the role of “Treach” in the upcoming “Salt N Peppa” Biopic. Jermel is also a New York “Black Top” legendary, “And-1” style basketball player who is perfect for celeberity sport events. https://www.imdb.com/videoplayer/vi140885785 • ANGELO DIAZ TvOne #1 Show ATLHomicide: Angelo Diaz is a fashion plate. He is accompanied by a cinematographer who promotes, films, and distributes the content on the #ATLHomicide’ stars media platforms. Angelo is athletic, is also great for celeberity sport events ANGELO DIAZ CREDITS IMDb: https://m.imdb.com/name/nm7921534/?ref_=m_nv_sr_1 --       www.FUpCancer.com Move Powerfully,  Black Nicholson Atlanta . Germany . Johannesburg www.omenagency.com +404.910.7035 - IG, FB, SnapChat, @omenagency  The Worlds #1 One Stop Shop for your Business and Entertainment Needs. The Omen Agency is a full service Marketing, Promotions, Production, Booking company. Keep an eye out for the Omen Agency, “A sign of things to come” Check out Weekly HipHop News "What It Be World - This Week In HipHop" alongside 7 Million Listeners in Africa www.whatitbeworld.net & follow us on Twitter & IG @whatitbeworld --- Support this podcast: https://anchor.fm/van-keeto2/support

BLACK NICHOLSON - A well-known and highly regarded fixture in the Atlanta entertainment Industry over the past 25 years, Mr. Nicholson is involved in all facets of the business from onstage to behind the scenes. Black has worked in all areas of the music industry from BMG/Sony street team manager to Major Label signed recording artist, to Artist Manager handling six figure budgets, to owner, and er and operator of The Omen Agency, a full service booking agency, production company and venue based in Atlanta, Germany, Lagos and Johannesburg. Most recently Black secured a historic deal for singer-songwriter Tina P.  Black Nicholson, has also hosted and co-creator of "What It Be! This week in HipHop" a highly entertaining Radio show on S.A.'s 5FM that looked at the US scene, while interweaving local artists and news throughout Africa and in UK. Mr. Nicholson has also expanded into the film sector. Jermel Howard, Angelo Diaz, and Markice Moore are apart of Black’s client roster (see links below). • The Omen Agency is a full service Marketing, Promotions, Production, Booking company and venue based in Atlanta, Germany, Lagos and Johannesburg. We exercise a worldwide vision with you in mind. Our facilities include a record company, a fully staffed marketing team, a digital/physical distribution company, and a multi-media entertainment firm equipped with a team of agents and sales associates at your disposal. At The Omen Agency we develop entertainers from start to finish all under one roof. Keep an eye out for the Omen Agency, “A sign of things to come” • The Omen Agency takes Rick Ross to South Africa: https://m.youtube.com/watch?v=71fhLXeWuxY Omen Agency In-House Endorsements: https://m.youtube.com/watch?v=tSOzTFEqc88 #FUPCancer Birthday Bash: https://m.youtube.com/watch?v=S53-pa0Pw3I#searching https://m.youtube.com/watch?v=XcqKe-6N07g   OMEN AGENCY CYPHERS, R&B Nights, etc: https://m.youtube.com/c/TheOmenAgencyAtlanta/videos?disable_polymer=true&itct=CBUQ8JMBGAEiEwiZm52_-MLqAhUCHWQKHcoRBOI%3D&disable_polymer=true&rootVe=3611&disable_polymer=true&rootVe=3611&disable_polymer=true&rootVe=3611 •  Tina P’s “i Think i Fell” ft Stand Up In It Man Theodis Ealey.  Click the FREE “DJ PACK” link at the bottom of the page.  It contains the clean, inst, & Accp. Give the Family my love. ENJOY! http://go.iamtinapittman.com/album/i-think-i-fell/ • JERMEL HOWARD (ACTOR/DIRECTOR): Jermel Howard was chosen for the role of “Treach” in the upcoming “Salt N Peppa” Biopic. Jermel is also a New York “Black Top” legendary, “And-1” style basketball player who is perfect for celeberity sport events. https://www.imdb.com/videoplayer/vi140885785 • ANGELO DIAZ TvOne #1 Show ATLHomicide: Angelo Diaz is a fashion plate. He is accompanied by a cinematographer who promotes, films, and distributes the content on the #ATLHomicide’ stars media platforms. Angelo is athletic, is also great for celeberity sport events ANGELO DIAZ CREDITS IMDb: https://m.imdb.com/name/nm7921534/?ref_=m_nv_sr_1 --       www.FUpCancer.com Move Powerfully,  Black Nicholson Atlanta . Germany . Johannesburg www.omenagency.com +404.910.7035 - IG, FB, SnapChat, @omenagency  The Worlds #1 One Stop Shop for your Business and Entertainment Needs. The Omen Agency is a full service Marketing, Promotions, Production, Booking company. Keep an eye out for the Omen Agency, “A sign of things to come” Check out Weekly HipHop News "What It Be World - This Week In HipHop" alongside 7 Million Listeners in Africa www.whatitbeworld.net & follow us on Twitter & IG @whatitbeworld --- Support this podcast: https://anchor.fm/van-keeto2/support

Hymn

Rev. Dr. Kay Morris Rev. Dr. Kay Morris is a Gospel Hall of Famer; she is a Grammy Considered singer/songwriter. Dr. Morris is a Global Humanitarian/Philanthropist, Ordained Reverend, Fashion Designer, Women/Youth Empowerment Conference Speaker, Youth Mentor, and Evangelist. In October 2019 Rev. Dr. Kay Morris had a milestone accomplishment; she was one of first 7 Women to be Ordained to the Office of Bishop in the Pentecostal Church Of God during their 100 Years Anniversary Celebration Service. She holds a Bachelor of Divinity Degree, Doctor of Divinity Degree and Doctor of Humanities Degree. She is the President and Founder of the Kay Morris Foundation being the Voice Of The Voiceless for orphans and people living with HIV/AIDS in Africa and other parts of the world.  She has won over 50 music and humanitarian awards around the world.  The Canadian Gospel Legend has twice been featured in the Toronto Star by Journalist Geoff Chapman who states, “Kay Morris brings to mind the commanding voice of Mavis Staple of the staple singers.” She has performed at Stellar Awards, Dove Awards, Grammy Awards sanctioned events. She has also performed several times on Dr. Bobby Jones Gospel. Her latest single Abba Oh was voted in the First-Round voting ballots at the 62nd Grammy Awards; Abba Oh single was also included in the Billboard Magazine Contenders Issue - released on news stands September 21st, 2019. The Academy Awards invited her to attend the Grammy Awards in Los Angeles, California. While in LA for Grammy weekend, she toured the Grammy museum and made special Red-Carpet guest appearances at the Soiree held at the prestigious Roosevelt Hotel. Rev. Dr. Kay Morris is a Jamaican by birth; she resides in Toronto, Canada with her family. She was raised by two Pentecostal Minister Parents and started singing at the tender age of 4; her ministry experience spans more that 50 years. Kay Morris music has allowed her to travel all around the world crossing cultural, racial, and religious barriers, performing to audiences of over 200,000 people. The Electrifying Kay Morris takes over the stage captivating her audiences, as she ministers under the Power of The Anointing. Recently she visited Asia (China and South Korea) where she preached The Gospel, empowered young Ministers, Pastors and Lay Leaders, and ministered in music. In 2006 Kay Morris was enstooled Queen Nana Oye Sika I, in Ghana W. Africa after brokering $1.5 million in anti retro virals medicines for people living with AIDS in Africa. In 2012 K1ay Morris (Kay Morris Foundation) was invited as a Delegate Representative to attend the World Bank Annual Meeting - Civil Society Policy Forum in Tokyo, Japan where she participated in various panel discussions on topics about alleviating poverty and health issues in Africa and The Caribbean. In 2016 during President Barak Obama's Administration, Dr. Kay Morris was invited to the White House in Washington, DC as a Delegate to attend the Third Annual Caribbean & African International Leadership Conference and Awards Gala. She also met with Congressional Leaders and was one of the artists who performed at the White House. October 2016 - Dr. Kay Morris received the BEFFTA Global Humanitarian Award in London, UK. Previous recipients of BEFFTA Special honorary awards includes Sir Trevor McDonald OBE, Sir Lenny Henry, Omotola Jelade Ekeinde and Quincy Jones. In July 2019, Kay Morris received the UN ECOSOC World Excellence Sustainable Development Award and was also selected as UN Ambassador for Peace to represent ACCP at the UN Headquarters in New York and other parts of the world. Kay Morris sang on the short film soundtrack Sleeping Dogs Lie. Her music has been featured in many TV sit-com --- Support this podcast: https://anchor.fm/momentsofgrace/support

Caring for critically ill pregnant patients poses a series of unique challenges for the intensivist. In part two of this two-episode series, we discuss critical care in pregnancy with Dr. Stephen Lapinsky. Dr. Lapinsky is a practicing intensivist and professor of medicine at the University of Toronto. He is a member of the editorial board of the journal, Obstetric Medicine, and sits on the steering committee of the North American Society of Obstetric Medicine. Dr. Lapinsky is also the executive of the Women’s Health Network of the ACCP. Today (Part 2) we will cover general conditions that may lead to critical illness in pregnant women. Additional Resources: Practice bulletin on Critical Care in Pregnancy from the American College of Obstetrics and Gynecology (ACOG): https://bit.ly/2OtJARU A comprehensive review on acute respiratory failure in pregnancy: https://bit.ly/2DKzwjl AHA scientific statement on cardiac arrest in pregnancy: https://bit.ly/2QpGWtK

Caring for critically ill pregnant patients poses a series of unique challenges for the intensivist. In this two-episode series, we discuss critical care in pregnancy with Dr. Stephen Lapinsky. Dr. Lapinsky is a practicing intensivist and professor of medicine at the University of Toronto. He is a member of the editorial board of the journal, Obstetric Medicine, and sits on the steering committee of the North American Society of Obstetric Medicine. Dr. Lapinsky is also the executive of the Women’s Health Network of the ACCP. Today (Part 1) will cover unique conditions associated with pregnancy that may lead to critical illness. Additional Resources: Practice bulletin on Critical Care in Pregnancy from the American College of Obstetrics and Gynecology (ACOG): https://bit.ly/2OtJARU A comprehensive review on acute respiratory failure in pregnancy: https://bit.ly/2DKzwjl AHA scientific statement on cardiac arrest in pregnancy: https://bit.ly/2QpGWtK

Topics in PH: Review of the ACCP PAH Treatment Guideline

Episode 34: ACCP Podcast for Residents by Residents: Mentorship

This is a conversation I had with Marcus Peck (@ICUltrasonica) who is the chair of the FICE committee (Focussed Intensive Care Echocardiography) and Hannah Conway who is an ACCP at Glenfield Hospital and is VERY qualified when it comes to ultrasound and echocardiography. It would seem that Marcus and colleagues are very keen for us to do echo! […] The post CCP Podcast 082: FICE…Just Do It! appeared first on Critical Care Practitioner.

This is a conversation I had with Marcus Peck (@ICUltrasonica) who is the chair of the FICE committee (Focussed Intensive Care Echocardiography) and Hannah Conway who is an ACCP at Glenfield Hospital and is VERY qualified when it comes to ultrasound and echocardiography. It would seem that Marcus and colleagues are very keen for us to do echo! […]

This is an important update from Carole Boulanger and Dr Simon Gardener at the 5th NAACCP conference in London 2017 about some of the changes anticipated for the ACCP body and how they hope the future will pan out. It is only short but full of lots of useful, and very encouraging information. Interview Questions for […]

This is an important update from Carole Boulanger and Dr Simon Gardener at the 5th NAACCP conference in London 2017 about some of the changes anticipated for the ACCP body and how they hope the future will pan out. It is only short but full of lots of useful, and very encouraging information. Interview Questions for […] The post ACCP Update at 5th NAACCP Conference London 2017 appeared first on Critical Care Practitioner.

I was lucky to be asked to give a presentation about the role and the training of the Advanced Critical Care Practitioner at the 14th Critical Care Symposium in Manchester this year. This is the audio from that meeting as a podcast and I have also linked to the video with audio and slides combines. […]

  I was lucky to be asked to give a presentation about the role and the training of the Advanced Critical Care Practitioner at the 14th Critical Care Symposium in Manchester this year. This is the audio from that meeting as a podcast and I have also linked to the video with audio and slides combines. […] The post CCP Podcast 065: ACCP Presentation at Critical Care Symposium 2017 appeared first on Critical Care Practitioner.

Ovarian vein thrombosis was recently the subject of a clinical review by the American College of OBGYN in November 2017. Ovarian vein thrombosis occurs in 1 and 600 to 1 in 2000 pregnancies and may have severe sequelae including pulmonary embolism. In this podcast, we will review the latest information from the ACOG and the ACCP on the pathophysiology, diagnosis, and treatment of ovarian vein thrombosis.

Welcome back to the VTE Dublin Podcast where you’ll find all the recent talks from the VTE Dublin Conference. Clive Kearon is Professor of Medicine at McMaster University and a leading researcher in VTE and was the author of the most recent ACCP guidelines on VTE management. Be sure to subscribe to the VTE Dublin Podcast […]

Welcome back to the new VTE Dublin Podcast where you’ll find all the recent talks from the VTE Dublin Conference. Clive Kearon is Professor of Medicine at McMaster University and a leading researcher in VTE and was the author of the most recent ACCP guidelines on VTE management. Be sure to subscribe to the VTE Dublin […]

Bob John, PharmD hosts PPAG Conversations, the official Podcast of the Pediatric Pharmacy Association. Dr. John speaks with experts in the field of pediatric pharmacy to discuss current issues in pediatric pharmacy, including pediatric and neonatal critical care, general pediatrics, and hematology/oncology.   During this Podcast, Dr. John and Dr. Diana Yu discuss this year's flu season About our Guest   Diana Yu, PharmD, BCPS, AQ-ID is a Pediatric Infectious Diseases Pharmacist at the Doernbecher Children's Hospital at Oregon Health and Science University in Portland, Oregon.  Previously to her current appointment Dr. Yu was an Adjunct Clinical Assistant Professor at the University of Missouri-Kansas City (UMKC) and University of Kansas Schools of Pharmacy and Clinical Infectious Disease pharmacist and member of the Antimicrobial Stewardship Program at Children’s Mercy. She completed her pharmacy degree at University of California-San Francisco School of Pharmacy. After graduation, Dr. Yu completed a Pharmacy Practice Residency at University of Kentucky Medical Center followed by a HIV Care/Infectious Diseases Residency at University of Illinois at Chicago. She achieved board certification as a Pharmacotherapy Specialist with added qualifications in Infectious Diseases in 2015. She currently participates routinely in the Antimicrobial Stewardship Program at Children’s Mercy Hospital and is a preceptor for both student pharmacists and pharmacy residents. Her current research interests include the role of antimicrobial stewardship in decreasing antibiotic resistance and clinical outcomes, non-occupational HIV post-exposure prophylaxis, and the role of rapid diagnostics and antimicrobial stewardship        About the Host of PPAG Conversations Bob John, Pharm.D., BCPS, BCPPS, a member of the PPAG Board of Directors, is currently a NICU Clinical Pharmacy Specialist at The Children’s Hospital at Saint Francis and the Residency Program Director for his institution’s PGY1. He completed a PGY1 residency at Saint Francis Hospital and a PGY2 residency at The University of Oklahoma College of Pharmacy. He spent his first two years after residency working as the Pediatric Pulmonology Specialist at Children’s Mercy Hospital and Clinics, after which he worked as a Clinical Assistant Professor of Pediatric Pharmacotherapy, Department of Pharmacy at The University of Oklahoma College of Pharmacy. Dr. John has been involved with the development of a pharmacy-driven pharmacokinetic monitoring service, NICU dosing weight protocol, and served on the evidence-based medicine committee, in which he has helped develop clinical practice guidelines at his institutions. Dr. John has been an active member of PPAG since 2007. In addition to being a member of the education committee, he has served as the chair of the webinar committee, and the education committee where he organized the educational content provided at the 2016 PPAG annual meeting. In 2015, he and his colleagues were recognized by PPAG with a Best Practice Award for their development of an outpatient on call service. He was awarded the Presidential Citation from PPAG in 2014 and 2016. He currently chairs the web-based competency committee, working to provide additional educational content in new ways to PPAG members. In addition to his work in PPAG, he served as Chair of the Pediatric PRN for ACCP.   Introduction music credits: "Reverie (small theme)" by _ghost 2010 - Licensed under Creative Commons Attribution (3.0)

Welcome back to the new VTE Dublin Podcast where you’ll find all the recent talks from the VTE Dublin Conference. Clive Kearon is Professor of Medicine at McMaster University and a leading researcher in VTE and was the author of the most recent ACCP guidelines on VTE management. Be sure to subscribe to the VTE Dublin […]

Bob John, PharmD hosts PPAG Conversations, the official Podcast of the Pediatric Pharmacy Association. Dr. John speaks with experts in the field of pediatric pharmacy to discuss current issues in pediatric pharmacy, including pediatric and neonatal critical care, general pediatrics, and hematology/oncology.   During this Podcast, Dr. John hosts Dr. Jamie Miller, who highlights a newly published article in The Lancet, titled, "Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial." About our Guest Jamie Miller, Pharm.D., BCPS, BCPPS is an Associate Professor in the Department of Pharmacy Clinical and Administrative Sciences at the University of Oklahoma College of Pharmacy in Oklahoma City, Oklahoma. Dr. Miller received her Doctor of Pharmacy degree from Southwestern Oklahoma State University College of Pharmacy. Following graduation, Dr. Miller completed a PGY1 Pharmacy Practice Residency and PGY2 Pediatric Pharmacy Practice Residency at the University of Oklahoma College of Pharmacy. Dr. Miller currently practices as a Clinical Pharmacy Specialist in the Neonatal Intensive Care Unit at the Children’s Hospital at OU Medical Center in Oklahoma City. In addition, Dr. Miller is the Residency Program Director for the PGY1 Pharmacy Practice Residency at the University of Oklahoma College of Pharmacy and OU Medical Center.         About the Host of PPAG Conversations Bob John, Pharm.D., BCPS, BCPPS, a member of the PPAG Board of Directors, is currently a NICU Clinical Pharmacy Specialist at The Children’s Hospital at Saint Francis and the Residency Program Director for his institution’s PGY1. He completed a PGY1 residency at Saint Francis Hospital and a PGY2 residency at The University of Oklahoma College of Pharmacy. He spent his first two years after residency working as the Pediatric Pulmonology Specialist at Children’s Mercy Hospital and Clinics, after which he worked as a Clinical Assistant Professor of Pediatric Pharmacotherapy, Department of Pharmacy at The University of Oklahoma College of Pharmacy. Dr. John has been involved with the development of a pharmacy-driven pharmacokinetic monitoring service, NICU dosing weight protocol, and served on the evidence-based medicine committee, in which he has helped develop clinical practice guidelines at his institutions. Dr. John has been an active member of PPAG since 2007. In addition to being a member of the education committee, he has served as the chair of the webinar committee, and the education committee where he organized the educational content provided at the 2016 PPAG annual meeting. In 2015, he and his colleagues were recognized by PPAG with a Best Practice Award for their development of an outpatient on call service. He was awarded the Presidential Citation from PPAG in 2014 and 2016. He currently chairs the web-based competency committee, working to provide additional educational content in new ways to PPAG members. In addition to his work in PPAG, he served as Chair of the Pediatric PRN for ACCP.   Introduction music credits: "Reverie (small theme)" by _ghost 2010 - Licensed under Creative Commons Attribution (3.0)

Bob John, PharmD hosts PPAG Conversations, the official Podcast of the Pediatric Pharmacy Association. Dr. John speaks with experts in the field of pediatric pharmacy to discuss current issues in pediatric pharmacy, including pediatric and neonatal critical care, general pediatrics, and hematology/oncology.   During this Podcast, Dr. John hosts Dr. Nicholas Fusco, who highlights a newly published article in the New England Journal of Medicine, titled, "Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children." About our Guest Nicholas M. Fusco, PharmD, BCPS, is employed as Clinical Assistant Professor, Department of Pharmacy Practice at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences (UB-SPPS), since 2013.  Dr. Fusco earned his PharmD from UB-SPPS (2010) and completed his PGY1 Pharmacy Practice and PGY2 Pediatric Specialty residencies at the University of Maryland School of Pharmacy (2010-2012). He received his Board Certification in Pharmacotherapy (BCPS) in 2011. Dr. Fusco practices and teaches in acute care general pediatrics. Very active in PPAG, Dr. Fusco has served as Chair of the Fall and Annual Conference Planning Committees, and the Education Committee.       About the Host of PPAG Conversations Bob John, Pharm.D., BCPS, BCPPS, a member of the PPAG Board of Directors, is currently a NICU Clinical Pharmacy Specialist at The Children’s Hospital at Saint Francis and the Residency Program Director for his institution’s PGY1. He completed a PGY1 residency at Saint Francis Hospital and a PGY2 residency at The University of Oklahoma College of Pharmacy. He spent his first two years after residency working as the Pediatric Pulmonology Specialist at Children’s Mercy Hospital and Clinics, after which he worked as a Clinical Assistant Professor of Pediatric Pharmacotherapy, Department of Pharmacy at The University of Oklahoma College of Pharmacy. Dr. John has been involved with the development of a pharmacy-driven pharmacokinetic monitoring service, NICU dosing weight protocol, and served on the evidence-based medicine committee, in which he has helped develop clinical practice guidelines at his institutions. Dr. John has been an active member of PPAG since 2007. In addition to being a member of the education committee, he has served as the chair of the webinar committee, and the education committee where he organized the educational content provided at the 2016 PPAG annual meeting. In 2015, he and his colleagues were recognized by PPAG with a Best Practice Award for their development of an outpatient on call service. He was awarded the Presidential Citation from PPAG in 2014 and 2016. He currently chairs the web-based competency committee, working to provide additional educational content in new ways to PPAG members. In addition to his work in PPAG, he served as Chair of the Pediatric PRN for ACCP. Introduction music credits: "Reverie (small theme)" by _ghost 2010 - Licensed under Creative Commons Attribution (3.0)

Bob John, PharmD hosts PPAG Conversations, the official Podcast of the Pediatric Pharmacy Association. Dr. John speaks with experts in the field of pediatric pharmacy to discuss current issues in pediatric pharmacy, including pediatric and neonatal critical care, general pediatrics, and hematology/oncology. During this Podcast, Dr. John hosts Tara Higgins, who highlights a newly published article in the Journal of Pediatric Hematology/Oncology, titled, "Retrospective Evaluation of Palifermin Use Nonhematopoietic Stem Cell Transplant Pediatric Patients," By Liu and colleagues. About the Guest Tara Higgins is an active member of PPAG, where she has served PPAG through numerous leadership positions. Tara, currently serving on the PPAG Board of Direcctors, was membership committee chair elect and chair (2013-2015) and chair of PPAG Fall Specialty Conference- Hematology/Oncology Planning Committee (2016). Currently, Tara serves PPAG as chair of hematology/oncology Special Interest Group (SIG) (2012-present), section lead for hematology/oncology section of PPAG board prep (2016- present), member of PPAG membership committee (2009-present) and member of PPAG BCPPS Recertification Committee (2016- present). Tara also helped start the PPAG student group at the University of Florida and continues to serve as the faculty advisor for PediaGators. Tara is Co-Director of the PGY-2 Pediatric Pharmacy Residency and is a clinical specialist in pediatric hematology/oncology/BMT at UF Health Shands Children’s Hospital. In addition, Tara serves as clinical assistant professor at the University of Florida College of Pharmacy. She received her Doctor of Pharmacy from the University of Rhode Island. Tara completed her PGY1 pharmacy practice residency at Massachusetts General Hospital and a PGY2 pediatric pharmacy residency at the University of Kentucky Chandler Medical Center.     About the Host of PPAG Conversations Bob John, Pharm.D., BCPS, BCPPS, a member of the PPAG Board of Directors, is currently a NICU Clinical Pharmacy Specialist at The Children’s Hospital at Saint Francis and the Residency Program Director for his institution’s PGY1. He completed a PGY1 residency at Saint Francis Hospital and a PGY2 residency at The University of Oklahoma College of Pharmacy. He spent his first two years after residency working as the Pediatric Pulmonology Specialist at Children’s Mercy Hospital and Clinics, after which he worked as a Clinical Assistant Professor of Pediatric Pharmacotherapy, Department of Pharmacy at The University of Oklahoma College of Pharmacy. Dr. John has been involved with the development of a pharmacy-driven pharmacokinetic monitoring service, NICU dosing weight protocol, and served on the evidence-based medicine committee, in which he has helped develop clinical practice guidelines at his institutions. Dr. John has been an active member of PPAG since 2007. In addition to being a member of the education committee, he has served as the chair of the webinar committee, and the education committee where he organized the educational content provided at the 2016 PPAG annual meeting. In 2015, he and his colleagues were recognized by PPAG with a Best Practice Award for their development of an outpatient on call service. He was awarded the Presidential Citation from PPAG in 2014 and 2016. He currently chairs the web-based competency committee, working to provide additional educational content in new ways to PPAG members. In addition to his work in PPAG, he served as Chair of the Pediatric PRN for ACCP.   Introduction music credits: "Reverie (small theme)" by _ghost 2010 - Licensed under Creative Commons Attribution (3.0)  

Bob John, PharmD hosts PPAG Conversations, the official Podcast of the Pediatric Pharmacy Association. Dr. John speaks with experts in the field of pediatric pharmacy to discuss current issues in pediatric pharmacy, including pediatric and neonatal critical care, general pediatrics, and hematology/oncology. During this Podcast, Dr. John hosts Dr. Peter Johnson, who highlights a newly published article in the Journal Critical Care Medicine, titled, "Delirium in Critically Ill Children: An International Point Prevalence Study." About our Guest Peter Johnson, Pharm.D. is an Associate Professor of Pharmacy Practice at the OU College of Pharmacy and Adjunct Associate Professor of Pediatrics at the OU College of Medicine. He also maintains an active practice site in the Medical and Surgical Pediatric ICU’s at the Children’s Hospital at OU Medical Center in Oklahoma City precepting PGY1/PGY2 residents and students. In addition, Dr. Johnson serves as the PGY2 Pediatric Pharmacy Practice Residency Director at the OU College of Pharmacy and The Children’s Hospital at OU Medical Center. Dr. Johnson received his B.S. in Pharmaceutical Sciences and Doctor of Pharmacy degrees from the University of Mississippi School of Pharmacy. Following his tenure at Ole Miss, Dr. Johnson completed his PGY1 pharmacy and PGY2 pediatric pharmacy residencies at the University of Kentucky Chandler Medical Center. Among his professional affiliations, he is a member of the Pediatric Pharmacy Advocacy Group, Society of Critical Care Medicine, American Society of Health-System Pharmacists, American, and American College of Clinical Pharmacy. Dr. Johnson is board certified in pharmacotherapy and pediatric pharmacy. In addition, he was inducted as a fellow of PPAG in 2016. His research/scholarship focuses in pain management, sedation, and drug withdrawal in critically-ill children.     About the Host of PPAG Conversations Bob John, Pharm.D., BCPS, BCPPS, a member of the PPAG Board of Directors, is currently a NICU Clinical Pharmacy Specialist at The Children’s Hospital at Saint Francis and the Residency Program Director for his institution’s PGY1. He completed a PGY1 residency at Saint Francis Hospital and a PGY2 residency at The University of Oklahoma College of Pharmacy. He spent his first two years after residency working as the Pediatric Pulmonology Specialist at Children’s Mercy Hospital and Clinics, after which he worked as a Clinical Assistant Professor of Pediatric Pharmacotherapy, Department of Pharmacy at The University of Oklahoma College of Pharmacy. Dr. John has been involved with the development of a pharmacy-driven pharmacokinetic monitoring service, NICU dosing weight protocol, and served on the evidence-based medicine committee, in which he has helped develop clinical practice guidelines at his institutions. Dr. John has been an active member of PPAG since 2007. In addition to being a member of the education committee, he has served as the chair of the webinar committee, and the education committee where he organized the educational content provided at the 2016 PPAG annual meeting. In 2015, he and his colleagues were recognized by PPAG with a Best Practice Award for their development of an outpatient on call service. He was awarded the Presidential Citation from PPAG in 2014 and 2016. He currently chairs the web-based competency committee, working to provide additional educational content in new ways to PPAG members. In addition to his work in PPAG, he served as Chair of the Pediatric PRN for ACCP. Introduction music credits: "Reverie (small theme)" by _ghost 2010 - Licensed under Creative Commons Attribution (3.0)

Bio for Dr. Lisa Dragic: Dr. Dragic received her PharmD from Temple University School of Pharmacy. Dr. Dragic is currently a PGY-1 pharmacy resident at the Samuel S. Stratton VA Medical Center in Albany, New York, with a concentration in pain management and palliative care. Her current research is focused on alcohol monitoring by ethyl glucuronide in patients on chronic opioid therapy. Upon completion of the PGY-1 residency, Dr. Dragic will be completing a PGY-2 in Pain Management and Palliative care at the Central Arkansas Veterans Healthcare System in Little Rock, Arkansas.   Bio for Dr. Jeffrey Fudin: Dr. Jeff Fudin graduated from Albany College of Pharmacy & Health Sciences with a BS and PharmD. He is a Diplomate to the Academy of Integrative Pain Management, a Fellow to ACCP and ASHP, and a member of several other professional organizations. He is President and Director, Scientific and Clinical Affairs for Remitigate, LLC (remitigate.com), a software platform for interpreting urine drug screens (Urintel) and risk for opioid-induced respiratory depression (Naloxotel). Dr. Fudin is a section editor for Pain Medicine and serves on the editorial board for Practical Pain Management. He practices as a clinical pharmacy specialist (WOC) and director of PGY-2 pharmacy pain residency programs at the Stratton Veterans Administration Medical Center in Albany, New York and has academic affiliations with Western New England University and Albany Colleges of Pharmacy. Statement regarding VA: This article is the sole work of the authors and stated opinions/assertions do not reflect the opinion of employers or employee affiliates. It was not prepared as part of the author(s) duty as federal employees.   See omnystudio.com/listener for privacy information.

Bio for Dr. Lisa Dragic: Dr. Dragic received her PharmD from Temple University School of Pharmacy. Dr. Dragic is currently a PGY-1 pharmacy resident at the Samuel S. Stratton VA Medical Center in Albany, New York, with a concentration in pain management and palliative care. Her current research is focused on alcohol monitoring by ethyl glucuronide in patients on chronic opioid therapy. Upon completion of the PGY-1 residency, Dr. Dragic will be completing a PGY-2 in Pain Management and Palliative care at the Central Arkansas Veterans Healthcare System in Little Rock, Arkansas.   Bio for Dr. Jeffrey Fudin: Dr. Jeff Fudin graduated from Albany College of Pharmacy & Health Sciences with a BS and PharmD. He is a Diplomate to the Academy of Integrative Pain Management, a Fellow to ACCP and ASHP, and a member of several other professional organizations. He is President and Director, Scientific and Clinical Affairs for Remi

Today's Pharmacy Podcast Show guest is Dr. Jeffrey Fudin. We're talking about the March 30th 2016 article from Pain News Network:  How Opioid Prescribing Guidelines Use Pseudoscience By Michael Schatman and Jeffrey Fudin, Guest Columnists Recently, we (along with our colleague, Dr. Jacqueline Pratt Cleary) published an open access article in the Journal of Pain Research, entitled “The MEDD Myth: The Impact of Pseudoscience on Pain Research and Prescribing Guideline Development.” In this work, we address the issue of how governmental and managed care opioid guideline prescribing committees use the flawed concept of morphine-equivalent daily dose (MEDD or MME) to arbitrarily place limits on the amount of opioids that a clinician “should” prescribe to any patient with chronic pain -- as if all patients were identical.  The article cites excellent research that exposes the invalid concept of MEDD – and while guideline authors are fully aware of that lack of evidence, they are hypocritically fine with using MEDD as a device to thwart chronic opioid use. In the case of opioids for chronic non-cancer pain, there is at least some evidence.  But for MEDD, there is no evidence. About:  Jeffrey Fudin, BS, PharmD, DAAPM, FCCP, FASHP   Dr. Jeff Fudin graduated from Albany College of Pharmacy & Health Sciences with a bachelor's degree and PharmD. He is a Diplomate to the American Academy of Pain Management, a Fellow to ACCP, a Fellow to ASHP, and a member of several other professional organizations. He is founder and CEO of Remitigate, LLC (remitigate.com), a software platform for interpreting urine drug screens (Urintel) and pharmacogenetics(Phenotel).   Dr. Fudin is a section editor for Pain Medicine and serves on the editorial board for Practical Pain Management. He is founder/chairman of Professionals for Rational Opioid Monitoring & Pharmacotherapy (PROMPT), an advocacy group in favor of safe opioid prescribing. He practices as a clinical pharmacy specialist and director of PGY-2 pharmacy pain residency programs at the Stratton Veterans Administration Medical Center in Albany, New York. He is an adjunct associate professor of pharmacy practice at Western New England University College of Pharmacy and an adjunct assistant professor of pharmacy practice at the University of Connecticut School of Pharmacy.   Dr. Fudin can also be found at his professional website, www.paindr.com. Contact Info:  Dr. Jeffrey Fudin  Email: jeff@paindr.com Twitter: @JeffreyFudin LinkedIn: linkedin.com/in/jeffreyfudin See omnystudio.com/listener for privacy information.

The American College of Chest Physicians (ACCP) is an interdisciplinary professional organization with almost 19,000 members worldwide. Around 2 years ago, the ACCP Board of Regents recognized that their programs and products would fill a real need for a global medical community, and started to explore growing beyond a traditional professional organization. This is an interview with Mark J. Rosen, MD, FCCP on what drove their research project and what lessons they've learned in implementing this initiative. Visit MCI Group on http://GrowGlobally.org to learn more.

ACCP Diagnosis and Management of Lung Cancer Guidelines Chair W. Michael Alberts, MD, FCCP, and Vice Chair Frank Detterbeck, MD, FCCP, join CHEST podcast editor for an overview of the newly released 3rd edition of the respected guidelines. Their discussion focuses on updates on recommendations for screening, advances in treatment, smoking cessation, and sympotom management and palliative care. (duration 33 min)

Antithrombotic Therapy and Prevention of Thrombosis, 9th ed Guidelines from the American College of Chest Physicians